Collective Molecular Activities of the Plant: Ixora Coccinea
Example Image
PLANiTS DNA barcode
Taxonomic Information
Used in Medicines
Country/Region:
Philippines; Indonesia; India; Vietnam; Thailand; NigeriaTraditional Medicine System:
Indian Folk; Ayurveda; SiddhaGeographical Distribution
Australia; Honduras; Bangladesh; Mexico; El Salvador; Gambia; Philippines; Indonesia; India; Costa Rica; Cambodia; Nicaragua; Senegal; Vietnam; Colombia; Sri Lanka; Thailand; Nigeria; Belize; Fiji
Geographical Distribution
See the Plant Occurrence Worldwide with Latitude and Longitude Available
Compounds Summary
Overview of Ingredients
28 All known Ingredients in Total
Unique ingredients have been isolated from this plant.Plant-Ingredients Associations were manually curated from publications or collected from other databases.
10 Ingredients with Acceptable Bioavailablity
Unique ingredients exhibit acceptable human oral bioavailablity, according to the criteria of SwissADME [PMID: 28256516] and HobPre [PMID: 34991690]. The criteria details:SwissADME: six descriptors are used by SwissADME to evaluate the oral bioavailability of a natural product:
☑ LIPO(Lipophility): -0.7 < XLOGP3 < +5.0
☑ SIZE: 150g/mol < MW < 500g/mol
☑ POLAR(Polarity): 20Ų < TPSA < 130Ų
☑ INSOLU(Insolubility): -6 < Log S (ESOL) < 0
☑ INSATU(Insaturation): 0.25 < Fraction Csp3 < 1
☑ FLEX(Flexibility): 0 < Num. rotatable bonds < 9
If 6 descriptors of a natural plant satisfy the above rules, it will be labeled high HOB.
HobPre: A natural plant ingredient with HobPre score >0.5 is labeled high human oral availability (HOB)
23 Ingredients with experimental-derived Activity
Unique ingredients have activity data available.Ingredient Structrual Cards
Ingredient ID: NPC79190
Ingredient ID: NPC76336
Ingredient ID: NPC51700
Ingredient ID: NPC473206
Ingredient ID: NPC469944
Ingredient ID: NPC469941
Ingredient ID: NPC469940
Ingredient ID: NPC469938
Ingredient ID: NPC469937
Ingredient ID: NPC44720
Ingredient ID: NPC36201
Ingredient ID: NPC279121
Ingredient ID: NPC278427
Ingredient ID: NPC267691
Ingredient ID: NPC261012
Ingredient ID: NPC249570
Ingredient ID: NPC249281
Ingredient ID: NPC246913
Ingredient ID: NPC219876
Ingredient ID: NPC218871
Ingredient ID: NPC192744
Ingredient ID: NPC192638
Ingredient ID: NPC182634
Ingredient ID: NPC181786
Ingredient ID: NPC170174
Ingredient ID: NPC148915
Ingredient ID: NPC126029
Ingredient ID: NPC116775
Classification of Human Proteins Collectively Targeted by the Plant
*The classification criteria of Drug Transporter (DTP), CYP450 are referred to DrugMap. Other molecular targets in CMAUP are classified as therapeutic targets.
.
Detailed Information of Target Proteins
| Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
|---|---|---|---|---|---|
| Cytochrome P450 | Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
| Cytochrome P450 | Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
| Cytochrome P450 | Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
| Cytochrome P450 | Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
| Cytochrome P450 | Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
| Therapeutic Target | Enzyme | CES1 | Acyl coenzyme A:cholesterol acyltransferase | P23141 | CHEMBL2265 |
| Therapeutic Target | Enzyme | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
| Therapeutic Target | Enzyme | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P05186 | CHEMBL5979 |
| Therapeutic Target | Enzyme | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
| Therapeutic Target | Enzyme | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
| Therapeutic Target | Isomerase | TOP2A | DNA topoisomerase II alpha | P11388 | CHEMBL1806 |
| Therapeutic Target | Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
| Therapeutic Target | Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
| Therapeutic Target | Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
| Therapeutic Target | Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
| Therapeutic Target | Metallo protease | MMP12 | Matrix metalloproteinase 12 | P39900 | CHEMBL4393 |
| Therapeutic Target | Methyl-lysine/arginine binding protein | SMN1 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
| Therapeutic Target | Nuclear hormone receptor subfamily 1 | RORC | Nuclear receptor ROR-gamma | P51449 | CHEMBL1741186 |
| Therapeutic Target | Nuclear hormone receptor subfamily 1 | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
| Therapeutic Target | Oxidoreductase | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
| Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
| Therapeutic Target | Protein Kinase | MKNK2 | MAP kinase signal-integrating kinase 2 | Q9HBH9 | CHEMBL4204 |
| Therapeutic Target | Protein Kinase | MTOR | Serine/threonine-protein kinase mTOR | P42345 | CHEMBL2842 |
| Therapeutic Target | Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
| Therapeutic Target | Protein Kinase | AURKA | Serine/threonine-protein kinase Aurora-A | O14965 | CHEMBL4722 |
| Therapeutic Target | Protein Kinase | MKNK1 | MAP kinase-interacting serine/threonine-protein kinase MNK1 | Q9BUB5 | CHEMBL4718 |
| Therapeutic Target | Secreted protein | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
| Therapeutic Target | Serine protease | DPP4 | Dipeptidyl peptidase IV | P27487 | CHEMBL284 |
| Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
| Therapeutic Target | Surface antigen | F3 | Coagulation factor III | P13726 | CHEMBL4081 |
| Therapeutic Target | Transcription factor | RELA | Nuclear factor NF-kappa-B p65 subunit | Q04206 | CHEMBL5533 |
| Therapeutic Target | Transcription factor | AHR | Aryl hydrocarbon receptor | P35869 | CHEMBL3201 |
| Therapeutic Target | Transcription factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
| Therapeutic Target | Transcription factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Clinical Trials Summary
Overview
Clinical trials associated with plant from natural product (NP) & plant level:
| Clinical trials type | Number of clinical trials | |
|---|---|---|
 NP level | 1236 | |
Clinical trial details
| NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
|---|---|---|---|---|
| NCT00912444 | Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT05290090 | ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05122455 | Effects of Edoxaban on Platelet Aggregation | myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT05179733 | The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01028079 | Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain | Low back pain | Aspirin (NPC311219) | NP level |
| NCT00004031 | SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02370680 | Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT00189137 | Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01015729 | Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately | peptic ulcer disease | Aspirin (NPC311219) | NP level |
| NCT01056679 | Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01426438 | Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate | HIV-1 infection | Aspirin (NPC311219) | NP level |
| NCT00635193 | Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT03164993 | Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer | breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01704716 | High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) | neuroblastoma | Doxorubicin (NPC261012) | NP level |
| NCT02605915 | Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00003896 | S9912 Combination Chemo in Stage III Ovarian Cancer, | fallopian tube cancer;ovarian cancer;peritoneum cancer | Doxorubicin (NPC261012) | NP level |
| NCT00878800 | A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01333423 | Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC) | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02326350 | ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial | acute respiratory distress syndrome | Aspirin (NPC311219) | NP level |
| NCT00923936 | Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma | Kaposi's sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03409198 | Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT05200312 | A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT03575520 | Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00549848 | Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00323323 | CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01622439 | Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00265018 | HD10 for Early Stages | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02132949 | A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01739556 | On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction | myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT01004978 | Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00269438 | New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis | ulcerative colitis | Aspirin (NPC311219) | NP level |
| NCT02326025 | A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01324076 | Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | liver cancer | Doxorubicin (NPC261012) | NP level |
| NCT02428751 | R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04780464 | A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00461344 | Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer | breast ductal carcinoma in situ | Doxorubicin (NPC261012) | NP level |
| NCT02271399 | Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty | venous thromboembolism | Aspirin (NPC311219) | NP level |
| NCT00051311 | Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers | hematopoietic and lymphoid cell neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT01396655 | PET in Breast Cancer Receiving Neoadjuvant Chemotherapy | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00210379 | Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00299182 | Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01712490 | A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01327521 | Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01527422 | Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00798252 | Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers | cancer | Doxorubicin (NPC261012) | NP level |
| NCT02427126 | Apixaban for Treatment of Embolic Stroke of Undetermined Source | stroke | Aspirin (NPC311219) | NP level |
| NCT03899987 | Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery | prostate adenocarcinoma | Aspirin (NPC311219) | NP level |
| NCT01788137 | A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients | T-cell acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT01569204 | Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02647099 | Adjuvant Low Dose Aspirin in Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT01990352 | Correlate BRCA1 Protein Expression With Response to DNA Damaging Chemotherapy | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT05036109 | DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease | colorectal carcinoma;malignant colon neoplasm | Aspirin (NPC311219) | NP level |
| NCT01637532 | Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00365365 | Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01204801 | Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02906761 | Aspirin for Uncontrolled Asthma | asthma | Aspirin (NPC311219) | NP level |
| NCT03197194 | A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion | retinal artery occlusion | Aspirin (NPC311219) | NP level |
| NCT01101594 | A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00206518 | Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02192021 | Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) | Cutaneous T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05210374 | Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02398240 | Brentuximab for Newly Diagnosed Hodgkin Disease | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04221035 | High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) | neuroblastoma | Doxorubicin (NPC261012) | NP level |
| NCT02895113 | Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes | diabetes mellitus | Aspirin (NPC311219) | NP level |
| NCT01882816 | Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer | thyroid cancer | Doxorubicin (NPC261012) | NP level |
| NCT02164864 | BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | atrial fibrillation | Aspirin (NPC311219) | NP level |
| NCT00194753 | Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT05406401 | A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00118209 | Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03571308 | A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL) | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02858258 | ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00038142 | Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients | Ewing sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01925612 | Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04066725 | Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma | cutaneous melanoma | Aspirin (NPC311219) | NP level |
| NCT01880866 | (-)-Epicatechin and Pulmonary Arterial Hypertension | pulmonary arterial hypertension | (-)-Epicatechin (NPC126029) | NP level |
| NCT02071004 | DS1040b/Aspirin Drug/Drug Interaction Study | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT01889069 | A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL) | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02448537 | A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02659930 | Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma | Kaposi's sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00108953 | A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT05159193 | Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01709994 | Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients | chronic kidney disease | Aspirin (NPC311219) | NP level |
| NCT01969578 | Androgen Deprivation Therapy in Advanced Salivary Gland Cancer | salivary gland cancer | Doxorubicin (NPC261012) | NP level |
| NCT00439296 | ABT-751 With Chemotherapy for Relapsed Pediatric ALL | childhood acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00223717 | Treatment of Supine Hypertension in Autonomic Failure | hypertension | Aspirin (NPC311219) | NP level |
| NCT01755520 | Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG | acute coronary syndrome;angina pectoris | Aspirin (NPC311219) | NP level |
| NCT01783535 | Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma | retinoblastoma | Doxorubicin (NPC261012) | NP level |
| NCT02675205 | Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm | brain aneurysm | Aspirin (NPC311219) | NP level |
| NCT00574236 | Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01100359 | Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer | endometrial cancer | Doxorubicin (NPC261012) | NP level |
| NCT01605526 | A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT04937088 | Outpatient Liquid Aspirin (OLA) | COVID-19 | Aspirin (NPC311219) | NP level |
| NCT02186834 | Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT03004287 | 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT05035316 | Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT) | bipolar disorder | Aspirin (NPC311219) | NP level |
| NCT01516567 | Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00174655 | BIG 02/98 Docetaxel - Breast Cancer | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02054559 | R-CHOP Alone vs. R-CHOP Plus Radiotherapy for Localized CD20+ DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04645004 | Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy | preeclampsia | Aspirin (NPC311219) | NP level |
| NCT00176293 | Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer | prostate cancer | Doxorubicin (NPC261012) | NP level |
| NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03758989 | A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03532698 | Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
| NCT00600977 | Liposomal Anthracyclin in the Treatment of Elderly ALL | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT04480099 | Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04517435 | ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05156879 | Aspirin for the Management of Endometriosis-associated Pelvic Pain | pain | Aspirin (NPC311219) | NP level |
| NCT01429272 | Minocycline and Aspirin in the Treatment of Bipolar Depression | bipolar disorder | Aspirin (NPC311219) | NP level |
| NCT01240629 | Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | prostate cancer | Doxorubicin (NPC261012) | NP level |
| NCT04139304 | A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01885013 | Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients | breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02710734 | Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) | urinary bladder carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01057069 | Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04077905 | Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis. | hemophagocytic syndrome | Doxorubicin (NPC261012) | NP level |
| NCT02732015 | Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00026208 | Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00204646 | Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03248427 | Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer. | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02275598 | Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00496769 | A Phase III Study of Apixaban in Patients With Atrial Fibrillation | atrial fibrillation | Aspirin (NPC311219) | NP level |
| NCT02776540 | Clopidogrel for Acute Ischaemia of Recent Onset | stroke | Aspirin (NPC311219) | NP level |
| NCT04638790 | First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05498259 | Orelabrutinib With R-CHOP-like Regimen for Patients With Newly Diagnosed Untreated Non-GCB DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01652261 | Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11) | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04159818 | Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04895358 | 9-ING-41 in Patients With Advanced Cancers | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT01858207 | Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01060904 | A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00137111 | Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00175032 | A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin | osteoarthritis;Peptic ulcer | Aspirin (NPC311219) | NP level |
| NCT03003520 | A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01272557 | Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial | carcinoma of liver and intrahepatic biliary tract | Doxorubicin (NPC261012) | NP level |
| NCT01185964 | A Study of Olaratumab in Soft Tissue Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00004179 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04293393 | Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01959490 | Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01328145 | Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease | chronic obstructive pulmonary disease | Aspirin (NPC311219) | NP level |
| NCT03678883 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02285062 | Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01220128 | Treatment With Pazopanib for Neoadjuvant Breast Cancer | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00265408 | Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT04330872 | An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke. | stroke | Aspirin (NPC311219) | NP level |
| NCT00193440 | Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01871766 | Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy | rhabdomyosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00005867 | Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03051646 | Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis | Fatigue | Aspirin (NPC311219) | NP level |
| NCT03056703 | Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets | pain | Aspirin (NPC311219) | NP level |
| NCT00312650 | Doxil and Gemcitabine in Recurrent Ovarian Cancer | ovarian carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02228512 | Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas | Castleman disease;diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00238667 | To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection | stroke | Aspirin (NPC311219) | NP level |
| NCT00801281 | First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance. | chronic lymphocytic leukemia;follicular lymphoma;lymphoplasmacytic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02918747 | PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01172223 | Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04968106 | Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00617591 | Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM) | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT04227990 | Plinabulin iv Solution in Prevention of TAC Induced Neutropenia | neutropenia | Doxorubicin (NPC261012) | NP level |
| NCT05270057 | Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies | Burkitts lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05100628 | A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03005015 | Lenvatinib in Second Line Endometrial Carcinoma | endometrial neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02379585 | Fasting on Newly Diagnosed Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02260622 | Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia | ischemia | Aspirin (NPC311219) | NP level |
| NCT00016406 | S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01328236 | Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia | plasma cell leukemia;multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT02421588 | Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT03699449 | An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION) | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT03497702 | Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03755804 | Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03042819 | Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00129389 | FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03117751 | Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT01548573 | Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00201318 | A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01856868 | Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study) | Becker muscular dystrophy | (-)-Epicatechin (NPC126029) | NP level |
| NCT01854255 | Intraperitoneal Aerosol Chemotherapy in Gastric Cancer | gastric cancer | Doxorubicin (NPC261012) | NP level |
| NCT00976911 | AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT01629329 | Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine | migraine disorder | Aspirin (NPC311219) | NP level |
| NCT00405756 | A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. | multiple myeloma | Aspirin (NPC311219) | NP level |
| NCT05265299 | Trial to Determine Effective Aspirin Dose in COPD | chronic obstructive pulmonary disease | Aspirin (NPC311219) | NP level |
| NCT03063541 | Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms | brain aneurysm | Aspirin (NPC311219) | NP level |
| NCT00357682 | A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia | esophageal cancer | Aspirin (NPC311219) | NP level |
| NCT02268565 | Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms | insomnia | Aspirin (NPC311219) | NP level |
| NCT04852367 | PanDox: Targeted Doxorubicin in Pancreatic Tumours | pancreatic ductal adenocarcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00135499 | R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03159897 | FIL Study on ABVD DD-DI as Upfront Therapy in HL. | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00189553 | Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse | fallopian tube cancer;ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00005584 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04203641 | L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer | pancreatic carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02965703 | Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma | colorectal adenoma | Aspirin (NPC311219) | NP level |
| NCT00431795 | Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01118026 | Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05467670 | Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT02293395 | A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT00499018 | Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03225924 | Study of Entospletinib (ENTO) in Newly Diagnosed DLBCL Patients With aaIPI>=1 Treated by Chemiotherapy | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00000151 | Early Treatment Diabetic Retinopathy Study (ETDRS) | Blindness;diabetic retinopathy | Aspirin (NPC311219) | NP level |
| NCT04295486 | Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty | venous thromboembolism | Aspirin (NPC311219) | NP level |
| NCT02326779 | Low-dose Aspirin Therapy for Esophageal Cancer | esophageal cancer | Aspirin (NPC311219) | NP level |
| NCT04962451 | Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke | stroke | Aspirin (NPC311219) | NP level |
| NCT00004727 | Antiplatelet Therapy to Prevent Stroke in African Americans | stroke | Aspirin (NPC311219) | NP level |
| NCT00401635 | END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin | endometrial cancer | Doxorubicin (NPC261012) | NP level |
| NCT00408408 | Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT05386524 | Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00203372 | Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299) | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00278109 | Partial Breast Irradiation With Chemotherapy | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00126191 | Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | Burkitts lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00559845 | A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00499122 | NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00455533 | Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00211185 | A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01964391 | A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00429299 | Wkly Taxol x 12 | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT01451515 | NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma | lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04996160 | Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2) | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT02951728 | Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01666444 | VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT04809818 | A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT00004010 | Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02578706 | Targeting Platelets in Chronic HIV Infection | HIV-1 infection | Aspirin (NPC311219) | NP level |
| NCT04021992 | GVD±R Regimen for ASCT-eligible Patients With Refractory/Relapsed DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02183220 | Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache | migraine disorder | Aspirin (NPC311219) | NP level |
| NCT01552798 | Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache | Headache | Aspirin (NPC311219) | NP level |
| NCT04790903 | A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03517137 | Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00568464 | Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) | Ewing sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02659384 | Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer | ovarian neoplasm | Aspirin (NPC311219) | NP level |
| NCT00970385 | Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02997358 | Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma | leiomyosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00808899 | Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma | neuroblastoma | Doxorubicin (NPC261012) | NP level |
| NCT05006664 | Brentuximab Vedotin in Combination With CHEP in Patient With PTCL | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00849472 | A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948) | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT04765228 | Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01796951 | Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers | nicotine dependence | Aspirin (NPC311219) | NP level |
| NCT00577629 | Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01087424 | Mini-CHOP and Rituximab in Patients Aged Over 80 Years | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00930605 | The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL) | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00988195 | Study of Pegylated Human Recombinant Arginase for Liver Cancer | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT05035277 | AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation | aortic stenosis | Aspirin (NPC311219) | NP level |
| NCT01650701 | A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01809379 | Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT01720108 | Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty | venous thromboembolism | Aspirin (NPC311219) | NP level |
| NCT01707823 | Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer | lung adenocarcinoma | Aspirin (NPC311219) | NP level |
| NCT03437070 | Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma | leiomyosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01100372 | Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Doxorubicin (NPC261012) | NP level |
| NCT00910065 | BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS) | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT00105209 | A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension | pulmonary arterial hypertension | Aspirin (NPC311219) | NP level |
| NCT01840592 | Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01526122 | Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration | atherosclerosis | Aspirin (NPC311219) | NP level |
| NCT03233347 | Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma | classic Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00057382 | T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT04263584 | Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02299999 | SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02224131 | Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling | stroke | Aspirin (NPC311219) | NP level |
| NCT00580333 | Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01848132 | Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI. | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01424982 | Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Doxorubicin (NPC261012) | NP level |
| NCT05234684 | A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05207514 | Compare the Efficacy and the Safety of Doxorubicin and Cyclophosphamide Followed by Taxotere Versus Doxorubicin and Cyclophosphamide Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00405613 | Aspirin Use and Postoperative Bleeding From Dental Extractions in a Healthy Population | hemorrhage | Aspirin (NPC311219) | NP level |
| NCT00087178 | Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01009970 | Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02733380 | Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00956930 | Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery | liver cancer | Doxorubicin (NPC261012) | NP level |
| NCT00631111 | Study Evaluating the Efficacy of an Ibuprofen Effervescent Tablet in the Treatment of Post-Surgical Dental Pain | pain | Aspirin (NPC311219) | NP level |
| NCT01459627 | Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI | myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT00869232 | UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT01131364 | Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02633137 | Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01214668 | Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors | neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT04661007 | To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00038610 | Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia | leukemia | Doxorubicin (NPC261012) | NP level |
| NCT01804127 | Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01516580 | Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients | leukemia;non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00725231 | Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP | angioimmunoblastic T-cell lymphoma;extranodal nasal NK/T cell lymphoma;unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02666742 | DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation | stroke | Aspirin (NPC311219) | NP level |
| NCT02548650 | Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus | myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT00525642 | Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00582725 | R-CHOP + GM-CSF for Previously Untreated LCL in Elderly | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03023046 | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04402385 | Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE) | preeclampsia | Aspirin (NPC311219) | NP level |
| NCT04584112 | A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer | triple-negative breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01839097 | Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL) | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00003215 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03103152 | A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression | prostate cancer | Aspirin (NPC311219) | NP level |
| NCT01476787 | Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00524810 | Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03646123 | Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00945724 | Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of Testis | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04877275 | ATG-010(Selinexor) in Combination With Chemotherapy in RRMM | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00000527 | Recurrent Carotid Stenosis | heart disease;internal carotid artery stenosis | Aspirin (NPC311219) | NP level |
| NCT02081638 | Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study | HIV infection | Aspirin (NPC311219) | NP level |
| NCT00750815 | Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM) | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT04081389 | Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer | breast carcinoma in situ | Doxorubicin (NPC261012) | NP level |
| NCT02419495 | Selinexor With Multiple Standard Chemotherapy or Immunotherapy Regimens in Treating Patients With Advanced Malignancies | cutaneous melanoma;metastatic melanoma;non-small cell lung carcinoma;renal cell carcinoma;breast carcinoma;Fallopian Tube Carcinoma;ovarian carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT05346107 | PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04498273 | COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 | COVID-19 | Aspirin (NPC311219) | NP level |
| NCT01661322 | Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke | stroke | Aspirin (NPC311219) | NP level |
| NCT02753881 | Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer | liver cancer | Doxorubicin (NPC261012) | NP level |
| NCT01042704 | Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
| NCT02838225 | DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00501059 | A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT00000479 | Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer | cerebrovascular disorder;Myocardial Ischemia;myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT04792723 | Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT04860804 | A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain | pain | Aspirin (NPC311219) | NP level |
| NCT00691912 | Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04145258 | Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis | meningitis | Aspirin (NPC311219) | NP level |
| NCT02626455 | Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03880695 | Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT04365309 | Protective Effect of Aspirin on COVID-19 Patients | COVID-19 | Aspirin (NPC311219) | NP level |
| NCT01200758 | A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03176498 | MK-5348-017) | cerebral infarction | Aspirin (NPC311219) | NP level |
| NCT00470301 | Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer | male breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01852435 | R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B | diffuse large B-cell lymphoma;follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01890005 | Low Dose Aspirin for the Prevention of Preeclampsia | preeclampsia | Aspirin (NPC311219) | NP level |
| NCT02098343 | p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246 | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT02869009 | Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT02607072 | Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT00262990 | Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneal neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT04032964 | Dose Finding Study of L19TNF and Doxorubicin in Patients With STS | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03787927 | Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets | hemorrhage | Aspirin (NPC311219) | NP level |
| NCT02158806 | Low Dose Aspirin for Venous Leg Ulcers | varicose ulcer | Aspirin (NPC311219) | NP level |
| NCT00303108 | Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01790997 | Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT02062255 | Impact of COX2 on Sera Biomarkers From Obese Subjects | breast cancer | Aspirin (NPC311219) | NP level |
| NCT01865110 | R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00911183 | Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03698227 | OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00250874 | Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04664972 | The TP Regimen in the Treatment of Early Triple Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00350948 | Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer | ovarian neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02723994 | A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia | leukemia | Doxorubicin (NPC261012) | NP level |
| NCT01078441 | Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT05371093 | Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04023916 | Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma. | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01705158 | Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT01455532 | A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors | neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00784537 | High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02362165 | CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT02855359 | Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma | diffuse large B-cell lymphoma;follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00379574 | Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01831011 | Mildronate for Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT00703170 | Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies | cancer | Doxorubicin (NPC261012) | NP level |
| NCT00061373 | Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT02181738 | Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05097248 | Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03188198 | Risk Adapted Therapy in Diffuse Large B Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04324463 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | COVID-19;severe acute respiratory syndrome | Aspirin (NPC311219) | NP level |
| NCT05105919 | Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
| NCT00006721 | S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01415336 | AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00935506 | Ex Vivo Human Thrombosis Chamber Study | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT01767155 | Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer | endometrial cancer | Doxorubicin (NPC261012) | NP level |
| NCT00004728 | Aspirin Or Warfarin To Prevent Stroke | atherosclerosis;cerebral infarction;stroke | Aspirin (NPC311219) | NP level |
| NCT00883116 | A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer | endometrial cancer | Doxorubicin (NPC261012) | NP level |
| NCT02945033 | Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT03170115 | Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer | rectum cancer | Aspirin (NPC311219) | NP level |
| NCT00684515 | Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005 | cerebral infarction | Aspirin (NPC311219) | NP level |
| NCT02995772 | Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04038489 | COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer | breast cancer | Doxorubicin (NPC261012);Aspirin (NPC311219) | NP level |
| NCT00795613 | Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL) | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05073718 | SARS-CoV-2 and Acetylsalicylic Acid (SARA) | COVID-19 | Aspirin (NPC311219) | NP level |
| NCT05238064 | Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL | mature T-cell and NK-cell non-Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02131480 | Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma | leiomyosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00486759 | A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma | neoplasm of mature B-cells | Doxorubicin (NPC261012) | NP level |
| NCT00136435 | A Study in Adults With Untreated Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT02449252 | Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01227941 | MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011) | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00002105 | Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma | Kaposi's sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT04650984 | A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01320982 | Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder | schizoaffective disorder;schizophrenia | Aspirin (NPC311219) | NP level |
| NCT02897700 | A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04383743 | Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer | urinary bladder carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00258960 | Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01935492 | 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer | breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01994720 | [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] | stroke | Aspirin (NPC311219) | NP level |
| NCT03542669 | Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer | ovarian carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02787239 | Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 and Rituximab in Combination With CHOP, in Previously Untreated Subjects With CD20+ DLBCL | neoplasm of mature B-cells | Doxorubicin (NPC261012) | NP level |
| NCT00093795 | Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00004067 | Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02333123 | Aspirin for Venous Ulcers: Randomised Trial (AVURT) | varicose ulcer | Aspirin (NPC311219) | NP level |
| NCT00003782 | Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00780039 | A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625) | ovarian neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT03378297 | IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC | ovarian cancer | Aspirin (NPC311219) | NP level |
| NCT01215344 | First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00630877 | Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin | Disorder of lipid metabolism | Aspirin (NPC311219) | NP level |
| NCT03961334 | MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention | stroke | Aspirin (NPC311219) | NP level |
| NCT04887961 | Reprab Study: PLD + Trabectedin Rechallenge | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00001300 | A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02164578 | Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Cardiovascular Disease | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
| NCT00809341 | R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00024102 | Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03161132 | Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT04824911 | Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease | stroke | Aspirin (NPC311219) | NP level |
| NCT00101101 | Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01702129 | Anti-EGFR Immunoliposomes in Solid Tumors | neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02689037 | Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis | cerebral atherosclerosis | Aspirin (NPC311219) | NP level |
| NCT01033526 | Symptomatic Treatment of Common Cold Symptoms | common cold | Aspirin (NPC311219) | NP level |
| NCT04874311 | Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00290732 | Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00626704 | Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT05088057 | Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01802775 | Edoxaban in Peripheral Arterial Disease | peripheral arterial disease | Aspirin (NPC311219) | NP level |
| NCT00516191 | A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00530101 | The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02846532 | Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure | thrombotic disease | Aspirin (NPC311219) | NP level |
| NCT00184002 | Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00212082 | Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00486512 | Chemoprevention of Colorectal Adenomas | Familial adenomatous polyposis | Aspirin (NPC311219) | NP level |
| NCT02034292 | Safety Study of APD-791 With Aspirin and/or Clopidogrel | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT05308030 | Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization | peripheral arterial disease | Aspirin (NPC311219) | NP level |
| NCT03598270 | Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer | ovarian carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00003595 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01139359 | Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02734771 | A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00722137 | Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00434031 | CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04757337 | Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00201708 | Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00903656 | Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02047539 | Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis | psychosis | Aspirin (NPC311219) | NP level |
| NCT04557475 | Transplacental Aspirin Therapy for Early Onset Fetal Growth Restriction | fetal growth restriction | Aspirin (NPC311219) | NP level |
| NCT03108300 | Use of Propranolol Hydrochloride in the Treatment of Metastatic STS | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02617485 | MabionCD20® Compared to MabThera® in Lymphoma Patients | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01388621 | Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT04214990 | Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients | gastric cancer | Aspirin (NPC311219) | NP level |
| NCT00072007 | Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL | leukemia | Doxorubicin (NPC261012) | NP level |
| NCT02439190 | CV004-007 Thrombosis Chamber Study | thrombotic disease | Aspirin (NPC311219) | NP level |
| NCT03860844 | Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | acute myeloid leukemia;acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00644085 | Does Low-Dose Aspirin Improve Outcome in In Vitro Fertilisation/Intra Cytoplasmatic Sperm Injection (IVF/ICSI)? | infertility | Aspirin (NPC311219) | NP level |
| NCT00577993 | Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02889523 | Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy | diffuse large B-cell lymphoma;follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04529772 | A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05056896 | ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT05051891 | A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01422109 | Comparative Pharmacokinetics of YH14659 | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT02449278 | The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05099666 | Lurbinectedin + Doxorubicin In Leiomyosarcoma | leiomyosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00790452 | Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma | glioblastoma multiforme | Aspirin (NPC311219) | NP level |
| NCT04506554 | A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer | urinary bladder carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02966119 | REstart or STop Antithrombotic Randomised Trial in France | hemorrhage | Aspirin (NPC311219) | NP level |
| NCT01490047 | Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03071926 | Metronomic PLD in Patients With Primary Endocrine Resistant ABC | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00384865 | A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension | pulmonary arterial hypertension | Aspirin (NPC311219) | NP level |
| NCT01831505 | Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00758732 | Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00635726 | Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer | urinary bladder cancer | Doxorubicin (NPC261012) | NP level |
| NCT02876302 | Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer | inflammatory breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02566993 | Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer | small cell lung carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01009801 | Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer | liver cancer | Doxorubicin (NPC261012) | NP level |
| NCT03647072 | PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01321255 | Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention. | myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT00093444 | Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors | liver cancer | Doxorubicin (NPC261012) | NP level |
| NCT02562378 | T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04078568 | Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease | mucocutaneous lymph node syndrome | Aspirin (NPC311219) | NP level |
| NCT00872534 | Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers | gastrointestinal disease | Aspirin (NPC311219) | NP level |
| NCT04025593 | Biomarker Guided Treatment in DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03225352 | A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets | pain | Aspirin (NPC311219) | NP level |
| NCT00783614 | Aspirin and Antiretroviral Therapy in HIV Infected Patients | HIV infection | Aspirin (NPC311219) | NP level |
| NCT04566887 | Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02911142 | Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma | B-cell neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT01920932 | Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00217425 | Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01492881 | Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT03819101 | Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer | prostate cancer | Aspirin (NPC311219) | NP level |
| NCT02938442 | Vaccination of Triple Negative Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03725059 | Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00722592 | Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04) | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00276380 | A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke | stroke | Aspirin (NPC311219) | NP level |
| NCT00180908 | Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children | osteosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01724021 | A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00727948 | The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy | breast cancer | Aspirin (NPC311219) | NP level |
| NCT00471965 | Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00816959 | Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00974324 | Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00060346 | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01355705 | Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
| NCT00841945 | Treatment of Aggressive Localized Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03553238 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00147225 | AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | cancer | Doxorubicin (NPC261012) | NP level |
| NCT01496521 | Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols | squamous cell carcinoma | Aspirin (NPC311219) | NP level |
| NCT01459887 | Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00346229 | Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00003907 | Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver | liver cancer | Doxorubicin (NPC261012) | NP level |
| NCT03618550 | Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02670317 | Phase II Study About Combination CHOP-21, Obinutuzumab and Ibrutinib in Untreated Young High Risk DLBCL Patients. | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02984384 | PREVENTion of Clot in Orthopaedic Trauma | injury;thrombotic disease | Aspirin (NPC311219) | NP level |
| NCT02792491 | Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00041938 | Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial | myocardial infarction;stroke | Aspirin (NPC311219) | NP level |
| NCT01309789 | A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms | anaplastic large cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00944801 | Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma | glioblastoma multiforme | Doxorubicin (NPC261012) | NP level |
| NCT00094497 | Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) | carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT04368377 | Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 | respiratory failure;viral pneumonia;COVID-19;venous thromboembolism | Aspirin (NPC311219) | NP level |
| NCT00808639 | Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma | urinary bladder cancer | Doxorubicin (NPC261012) | NP level |
| NCT00722293 | A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679) | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT04498793 | Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00609765 | Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors | pancreatic carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT03805022 | Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01358747 | Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00574080 | UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00893516 | CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00261586 | A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach | pain | Aspirin (NPC311219) | NP level |
| NCT04348032 | Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT03186456 | Human Umbilical Cord Mesenchymal Stem Cell Therapy (19 | cerebral infarction | Aspirin (NPC311219) | NP level |
| NCT01797575 | N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder | bipolar disorder | Aspirin (NPC311219) | NP level |
| NCT01622361 | Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02183688 | Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients | migraine disorder | Aspirin (NPC311219) | NP level |
| NCT03316534 | Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients | HIV infection | Aspirin (NPC311219) | NP level |
| NCT04466670 | Hemostasis in COVID-19: an Adaptive Clinical Trial | COVID-19 | Aspirin (NPC311219) | NP level |
| NCT00215943 | Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT03349281 | Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00268853 | A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00797472 | Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00998075 | Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately | peptic ulcer disease | Aspirin (NPC311219) | NP level |
| NCT00178464 | Aspirin Prophylaxis in Sickle Cell Disease | sickle cell anemia | Aspirin (NPC311219) | NP level |
| NCT00572169 | UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT01279291 | Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer | Fallopian Tube Carcinoma;ovarian neoplasm;peritoneal neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00258245 | Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | multiple myeloma | Aspirin (NPC311219) | NP level |
| NCT01851733 | MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme | glioblastoma multiforme | Doxorubicin (NPC261012) | NP level |
| NCT00440726 | Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT01468740 | Prospective Study on HIV-related Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00959621 | Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion | habitual abortion | Aspirin (NPC311219) | NP level |
| NCT00777673 | Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery. | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00264953 | HD11 for Intermediate Stages | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03290820 | Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients | nasopharyngeal neoplasm | Aspirin (NPC311219) | NP level |
| NCT02596126 | Secondary Prevention of Cardiovascular Disease in the Elderly Trial | myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT00574587 | Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | T-cell acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT02125409 | Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT03542266 | CC486-CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00002527 | Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT05318794 | Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer | gastric cancer | Doxorubicin (NPC261012) | NP level |
| NCT01082874 | PeriOperative ISchemic Evaluation-2 Trial | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT00244426 | S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation | atrial fibrillation | Aspirin (NPC311219) | NP level |
| NCT00688428 | Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination | gastrointestinal disease;ulcer disease | Aspirin (NPC311219) | NP level |
| NCT00566904 | New Topical Treatment for Continued Pain After Shingles | postherpetic neuralgia | Aspirin (NPC311219) | NP level |
| NCT03578822 | Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial | stroke | Aspirin (NPC311219) | NP level |
| NCT00193037 | Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01332968 | A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03377543 | Sleep and Inflammatory Resolution Pathway | inflammation | Aspirin (NPC311219) | NP level |
| NCT00361621 | Ph II CHOP+Velcade in Mediastinal LBCL | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04172259 | ACH-TH vs EC-TH as Neoadjuvant Therapy for HER2-positive EBC | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00940784 | Clopidogrel and Aspirin for the Treatment of Polycythemia Vera | polycythemia vera | Aspirin (NPC311219) | NP level |
| NCT00476190 | ALL Adult Consortium Trial: Adult ALL Trial | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT04575519 | Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis | tuberculosis | Aspirin (NPC311219) | NP level |
| NCT01259817 | Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) | essential thrombocythemia;polycythemia vera | Aspirin (NPC311219) | NP level |
| NCT01008150 | Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00715208 | Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01659307 | The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury | acute lung injury | Aspirin (NPC311219) | NP level |
| NCT00706953 | A Study of Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With Bortezomib | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT01168791 | Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00815945 | Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors | carcinosarcoma;leiomyosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00591851 | Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT05303792 | Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01246063 | Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00477412 | Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04229264 | Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients. | ischemia | Aspirin (NPC311219) | NP level |
| NCT03650933 | A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00789581 | A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00859495 | Trimodal Lung-Sparing Treatment of Pleural Mesothelioma | mesothelioma | Doxorubicin (NPC261012) | NP level |
| NCT00543829 | Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT04160546 | Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP) | chronic myelogenous leukemia | Aspirin (NPC311219) | NP level |
| NCT04332822 | A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01498588 | Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer | breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00165178 | Treatment of Acute Lymphoblastic Leukemia in Children | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00822120 | S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05428670 | The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma. | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02298283 | Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02313909 | Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) | stroke | Aspirin (NPC311219) | NP level |
| NCT00165087 | Treatment of Childhood Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT01696032 | SGI-110 in Combination With Carboplatin in Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT01110603 | A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1) | cancer | Doxorubicin (NPC261012) | NP level |
| NCT01675115 | Efficacy of BNG-1 to Treat Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT03564704 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL | lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04231448 | Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00369681 | Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00990860 | Study in Asia of the Combination of TACE With Sorafenib in HCC Patients | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT05189197 | A Study to Evaluate Efficacy and Safety of Zanubrutinib With R-CHOP in Newly Diagnosed Non-GCB DLBCL Patients With Double Expression | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02387086 | Gefitinib Combined With Thalidomide to Treat NSCLC | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
| NCT03407144 | Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00687440 | Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048) | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT03804866 | NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018) | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00311402 | JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme | stroke | Aspirin (NPC311219) | NP level |
| NCT00000496 | Platelet Drug Trial in Coronary Disease Progression | Myocardial Ischemia | Aspirin (NPC311219) | NP level |
| NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00312208 | Docetaxel in Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00319865 | PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT02622074 | Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02771743 | Response-based Treatment of High-risk Neuroblastoma | neuroblastoma | Doxorubicin (NPC261012) | NP level |
| NCT02505269 | Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00193115 | Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02063022 | Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma | Ewing sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00493870 | TAC Versus TC for Adjuvant Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02419820 | Dose-escalation, Repeated and Single Oral Dosing Study | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT04062032 | Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma | cutaneous melanoma | Aspirin (NPC311219) | NP level |
| NCT04569032 | A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01669239 | Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03145558 | TATE Versus TACE in Intermediate Stage HCC | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00608803 | Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors | cancer | Doxorubicin (NPC261012) | NP level |
| NCT04363840 | The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations | blood coagulation disease;Disseminated intravascular coagulation;vitamin D deficiency;COVID-19 | Aspirin (NPC311219) | NP level |
| NCT03949634 | Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD) | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02770274 | Cilostazol Following Peripheral Endovascular Procedures | peripheral arterial disease | Aspirin (NPC311219) | NP level |
| NCT00054938 | Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) | systemic lupus erythematosus | Aspirin (NPC311219) | NP level |
| NCT00068393 | Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma | renal cell carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00887536 | A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04224337 | Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma | non-small cell lung carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT03216876 | A Study Of Ursolic Acid For Primary Sclerosing Cholangitis | sclerosing cholangitis | Ursolic Acid (NPC51700) | NP level |
| NCT00004112 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04625907 | FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma | rhabdomyosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00523380 | Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT03712202 | Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma | classic Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00049595 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00671658 | Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00263211 | A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients | breast neoplasm | Aspirin (NPC311219) | NP level |
| NCT02602938 | Aspirin on CTCs of Advanced Breast and Colorectal Cancer | neoplasm | Aspirin (NPC311219) | NP level |
| NCT01281943 | Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00779129 | A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT01390584 | Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00169156 | A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma | angioimmunoblastic T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00590785 | Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00059306 | Secondary Prevention of Small Subcortical Strokes Trial | stroke | Aspirin (NPC311219) | NP level |
| NCT04679064 | Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT04754789 | Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI | ST Elevation Myocardial Infarction | Aspirin (NPC311219) | NP level |
| NCT05018520 | The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02797249 | Low Dose Aspirin in the Prevention of Preeclampsia in China | preeclampsia | Aspirin (NPC311219) | NP level |
| NCT00145639 | Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma | osteosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01861951 | A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01121406 | BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer | ovarian neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT04128956 | Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS | Venous thrombosis | Aspirin (NPC311219) | NP level |
| NCT02337933 | Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome | metabolic syndrome | Ursolic Acid (NPC51700) | NP level |
| NCT02529852 | A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00626392 | Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia | Disorder of lipid metabolism | Aspirin (NPC311219) | NP level |
| NCT00394251 | Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00450385 | Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP) | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00003150 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01211925 | Distal Venous Arterialisation of Ischemic Limb | ischemia | Aspirin (NPC311219) | NP level |
| NCT03201471 | Chidamide With R-CHOP Regimen for DLBCL Patients | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02285738 | Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | cancer | Aspirin (NPC311219) | NP level |
| NCT03192215 | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke | stroke | Aspirin (NPC311219) | NP level |
| NCT00129376 | Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02413320 | Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer | triple-negative breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02531308 | Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04240834 | Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT03609047 | Adjuvant Palbociclib in Elderly Patients With Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01796002 | Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01541332 | Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT03933319 | Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03952572 | Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02420652 | Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy | prostate carcinoma | Aspirin (NPC311219) | NP level |
| NCT00001339 | A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection | carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01275677 | Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer | breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00732927 | Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion | retinal vein occlusion | Aspirin (NPC311219) | NP level |
| NCT02813824 | Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome | Lynch syndrome | Aspirin (NPC311219) | NP level |
| NCT02292979 | Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00634179 | A Phase I/II Trial of VR-CHOP in Lymphoma Patients | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00587496 | 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers | Herpes simplex infection | Aspirin (NPC311219) | NP level |
| NCT05020860 | Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00925821 | Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT03101748 | Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer | breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02521285 | Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation | Barrett's esophagus | Aspirin (NPC311219) | NP level |
| NCT00968253 | RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT01887587 | Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia | acute lymphoblastic leukemia;lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02623972 | A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer | inflammatory breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02427620 | Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04554433 | New Treatment for COVID-19 Using Ethanol Vapor Inhalation . | COVID-19 | Aspirin (NPC311219) | NP level |
| NCT03274492 | A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01547741 | Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00136539 | Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00581360 | Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck | adenoid cystic carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00186849 | Therapy for Children With Advanced Stage High Risk Neuroblastoma | neuroblastoma | Doxorubicin (NPC261012) | NP level |
| NCT03428373 | Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
| NCT01100944 | A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies | Thymic Carcinoma;Thymoma | Doxorubicin (NPC261012) | NP level |
| NCT02301780 | Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention | preeclampsia | Aspirin (NPC311219) | NP level |
| NCT01321008 | Stage I/II Nasal NK Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00482261 | A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression | multiple myeloma | Aspirin (NPC311219) | NP level |
| NCT04153760 | Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity | venous thromboembolism | Aspirin (NPC311219) | NP level |
| NCT01646814 | Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects | duodenal ulcer | Aspirin (NPC311219) | NP level |
| NCT03236662 | (-)- Epicatechin Becker Muscular Dystrophy | Becker muscular dystrophy | (-)-Epicatechin (NPC126029) | NP level |
| NCT01940497 | A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00833833 | MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
| NCT01973205 | Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine | migraine disorder | Aspirin (NPC311219) | NP level |
| NCT00204568 | Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS) | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00186888 | Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma | retinoblastoma | Doxorubicin (NPC261012) | NP level |
| NCT01857934 | Therapy for Children With Advanced Stage Neuroblastoma | neuroblastoma | Doxorubicin (NPC261012) | NP level |
| NCT01616615 | Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation | placental insufficiency | Aspirin (NPC311219) | NP level |
| NCT00003165 | Doxorubicin in Treating Women With Advanced Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00565708 | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT01705691 | Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02055820 | A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | inflammatory breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02107378 | Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma | ovarian carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00003853 | 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT03491410 | Breast Cancer Active Surveillance, Alternative Option, Aspirin Included | breast cancer | Aspirin (NPC311219) | NP level |
| NCT01245608 | Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables. | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT01294462 | Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT03467178 | Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer. | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00554164 | Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04083963 | Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00209222 | Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01746173 | CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma | T-cell non-Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00871013 | Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT01974440 | A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05275777 | A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03341117 | Acetylsalicylic Acid and Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
| NCT02929888 | Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients | acute myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT03596281 | Pembrolizumab in Combination With Bevacizumab and Pegylated Liposomal Doxorubicin in Patients With Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT01186328 | EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00866749 | Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma | lymphoid leukemia;lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00000152 | Randomized Trial of Beta-Carotene and Macular Degeneration | macular degeneration | Aspirin (NPC311219) | NP level |
| NCT00486668 | A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02228772 | Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults | B-cell acute lymphoblastic leukemia;lymphoblastic lymphoma;T-cell acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT04443348 | Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00235248 | Aortic Arch Related Cerebral Hazard Trial (ARCH) | brain infarction;transient ischemic attack | Aspirin (NPC311219) | NP level |
| NCT03927313 | Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM | meningitis | Aspirin (NPC311219) | NP level |
| NCT00000157 | Randomized Trial of Aspirin and Cataracts in U.S. Physicians | cataract | Aspirin (NPC311219) | NP level |
| NCT00465673 | Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00450801 | R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05351346 | Genotype-guided Treatment in DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02116530 | Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy | Nausea and vomiting | Doxorubicin (NPC261012) | NP level |
| NCT03643276 | Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT04024462 | A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02239120 | Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) | stroke | Aspirin (NPC311219) | NP level |
| NCT03036488 | Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy as Neoadjuvant Treatment for Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-173/KEYNOTE-173) | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00451178 | A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04980222 | A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01657071 | Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT04043494 | International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma | lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01046942 | ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery | thrombophilia;thrombotic disease | Aspirin (NPC311219) | NP level |
| NCT00129805 | Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) | cerebral infarction | Aspirin (NPC311219) | NP level |
| NCT02596971 | A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02412670 | Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer | urothelial carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02735707 | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | COVID-19;influenza;pneumonia | Aspirin (NPC311219) | NP level |
| NCT02641847 | TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00083915 | DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00546156 | Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01762787 | Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers | inflammation | Aspirin (NPC311219) | NP level |
| NCT02671461 | Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" | thrombotic disease | Aspirin (NPC311219) | NP level |
| NCT01270373 | NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After? | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00326456 | MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00613457 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00331786 | Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT02832531 | INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority | rheumatic heart disease | Aspirin (NPC311219) | NP level |
| NCT02406092 | Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02237365 | A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis | meningitis | Aspirin (NPC311219) | NP level |
| NCT03574909 | IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes | diabetes mellitus | Aspirin (NPC311219) | NP level |
| NCT00324467 | Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | neoplasm of mature B-cells;non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00512980 | PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01998906 | A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01238185 | Aspirin Mouthwash in Treating Patients With Oral Leukoplakia | Oral leukoplakia | Aspirin (NPC311219) | NP level |
| NCT01057537 | UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT05491200 | Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients | myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT00365417 | Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02674958 | Mobilization of Endothelial Progenitor Cells and Aspirin | hypertrophic cardiomyopathy | Aspirin (NPC311219) | NP level |
| NCT05218499 | Brightline-1: A Study to Compare BI 907828 With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma | dedifferentiated liposarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00850512 | Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04656262 | Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00691236 | Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma | osteosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01358877 | A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00878254 | Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02685657 | Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04996004 | A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma | leiomyosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01285765 | Evaluate a Treatment Adapted to the PET Response Compared to a Standard Treatment, for Low Risk DLBCL CD 20+ Patients | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04243434 | PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients | Abnormality of blood and blood-forming tissues | Doxorubicin (NPC261012) | NP level |
| NCT02497820 | Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers | Lynch syndrome | Aspirin (NPC311219) | NP level |
| NCT00669773 | Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04824092 | Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01287741 | A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00699998 | A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT02989558 | A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI | aortic stenosis | Aspirin (NPC311219) | NP level |
| NCT02217501 | Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities | peripheral arterial disease | Aspirin (NPC311219) | NP level |
| NCT02445404 | Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02865811 | Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Doxorubicin (NPC261012) | NP level |
| NCT01329627 | Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT05422066 | Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04624984 | PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL | classic Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00124956 | Doxorubicin Pharmacokinetic (PK) Study | cancer | Doxorubicin (NPC261012) | NP level |
| NCT00734877 | UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT01672671 | BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03467373 | A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL | neoplasm of mature B-cells;non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01113957 | A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT02053597 | TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00961350 | A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers | gastric ulcer | Aspirin (NPC311219) | NP level |
| NCT02978495 | Neoadjuvant Carboplatin in Triple Negative Breast Cancer | Hereditary breast and ovarian cancer syndrome | Doxorubicin (NPC261012) | NP level |
| NCT03975205 | To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames | leukemia;lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00443677 | Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01779050 | Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00915733 | Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism | myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT00507962 | Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement | cancer | Doxorubicin (NPC261012) | NP level |
| NCT00002565 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03943901 | Split-Dose R-CHOP for Older Adults With DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03285607 | MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00657878 | Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00825149 | A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02049905 | Phase 3 Study to Treat Patients With Soft Tissue Sarcomas | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01635426 | Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages | pregnancy | Aspirin (NPC311219) | NP level |
| NCT01518231 | Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke | stroke | Aspirin (NPC311219) | NP level |
| NCT02958163 | Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR) | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00062023 | Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT03937830 | Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT04922567 | Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03412643 | Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00102609 | A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00225173 | Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02261805 | A Phase I/II Study of Ganetespib in Combination With Doxorubicin | small cell lung carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT04164368 | Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02867566 | A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03245489 | Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | head and neck malignant neoplasia | Aspirin (NPC311219) | NP level |
| NCT00484432 | Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT03405974 | Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip | osteonecrosis | Aspirin (NPC311219) | NP level |
| NCT05448820 | YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT04762901 | LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02798913 | Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD | peripheral arterial disease | Aspirin (NPC311219) | NP level |
| NCT04859465 | Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma | angiosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT04974996 | A Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of Loncastuximab Tesirine in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated Diffuse Large B-cell Lymphoma (LOTIS-8) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03023358 | Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00000510 | Platelet-Inhibitor Drug Trial in Coronary Angioplasty | angina pectoris;Myocardial Ischemia | Aspirin (NPC311219) | NP level |
| NCT01768637 | Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study | chronic kidney disease | Aspirin (NPC311219) | NP level |
| NCT00000491 | Aspirin-Myocardial Infarction Study (AMIS) | Myocardial Ischemia;myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT03498716 | A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01046825 | Mature B-Cell Lymphoma And Leukemia Study III | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03824938 | Aspirin for Exercise in Multiple Sclerosis (ASPIRE) | multiple sclerosis | Aspirin (NPC311219) | NP level |
| NCT01796197 | Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00305084 | Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors | cancer | Doxorubicin (NPC261012) | NP level |
| NCT03480776 | ASA in Prevention of Ovarian Cancer (STICs and STONEs) | ovarian cancer | Aspirin (NPC311219) | NP level |
| NCT05093920 | Role of DEB-TACE Versus c-TACE in Treatment of HCC | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02903004 | Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients | ovarian neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00819221 | AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours | neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT04381936 | Randomised Evaluation of COVID-19 Therapy | severe acute respiratory syndrome | Aspirin (NPC311219) | NP level |
| NCT00787527 | SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00082095 | To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01177683 | Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT01746238 | Bevacizumab/Doxorubicin/Radiation for Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01040871 | Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00581776 | Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03493854 | A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03396952 | Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma | cutaneous melanoma | Aspirin (NPC311219) | NP level |
| NCT01358071 | Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00736320 | HD16 for Early Stage Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02605694 | Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO) | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01206881 | Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00209209 | Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04343001 | Coronavirus Response - Active Support for Hospitalised Covid-19 Patients | COVID-19 | Aspirin (NPC311219) | NP level |
| NCT01324180 | Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT01453400 | Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain | pharyngitis | Aspirin (NPC311219) | NP level |
| NCT03018626 | R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03726879 | A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04358341 | Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer | gastric cancer | Doxorubicin (NPC261012) | NP level |
| NCT03192059 | Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer | cervical cancer;endometrial cancer | Aspirin (NPC311219) | NP level |
| NCT00316927 | Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer | prostate cancer | Aspirin (NPC311219) | NP level |
| NCT01271985 | Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT00719472 | A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE) | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04588727 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT00041210 | Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01655693 | Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01847001 | Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02032277 | A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03802071 | A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02772822 | A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00254592 | Neoadjuvant Treatment of Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00248248 | DOXIL for Consolidation Therapy in Ovarian Cancer. | ovarian neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00126243 | Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma | Lymphoma, AIDS-Related | Doxorubicin (NPC261012) | NP level |
| NCT03595592 | Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03384654 | A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT02472353 | Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00623779 | Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA) | atrial fibrillation | Aspirin (NPC311219) | NP level |
| NCT00266799 | The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071) | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02483247 | A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer | cancer | Doxorubicin (NPC261012) | NP level |
| NCT04910126 | Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01258634 | A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response | osteosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00191789 | Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03017326 | Paediatric Hepatic International Tumour Trial | Hepatoblastoma | Doxorubicin (NPC261012) | NP level |
| NCT02881086 | Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | acute lymphoblastic leukemia;lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03765619 | Postoperative Aspirin and Ankle Fracture Healing | bone fracture | Aspirin (NPC311219) | NP level |
| NCT00949325 | Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01514188 | Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00123929 | Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00003784 | S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00121992 | Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT01058902 | The Effect Of Aspirin On Survival in Lung Cancer | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
| NCT03678883 | 9-ING-41 in Patients With Advanced Cancers | lung neoplasm;Malignant Bone Neoplasm;malignant glioma;metastasis;kidney cancer;sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02488564 | A Study of Liposomal Doxorubicin + Docetaxel + Trastuzumab + Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04860713 | An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache | pain | Aspirin (NPC311219) | NP level |
| NCT00877006 | Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00479128 | Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors | urethra cancer | Doxorubicin (NPC261012) | NP level |
| NCT03464305 | ASPIRIN Trial Belgium | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
| NCT02467582 | Adjuvant Aspirin Treatment for Colon Cancer Patients | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
| NCT04101812 | Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer | urinary bladder cancer | Doxorubicin (NPC261012) | NP level |
| NCT01504867 | LIPS-A: Lung Injury Prevention Study With Aspirin | acute respiratory distress syndrome | Aspirin (NPC311219) | NP level |
| NCT01969032 | Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02979522 | A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01103440 | Aspirin Resistance and Percutaneous Coronary Intervention (PCI) | angina pectoris | Aspirin (NPC311219) | NP level |
| NCT00083226 | Doxorubicin and Bortezomib in Treating Patients With Liver Cancer | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00854568 | Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01356680 | HD17 for Intermediate Stage Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00790244 | A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00003578 | High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01966133 | TACE as an Adjuvant Therapy After Hepatectomy for HCC | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01649856 | A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00791947 | A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01802749 | Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00300365 | Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL | metabolic syndrome | Aspirin (NPC311219) | NP level |
| NCT02753647 | Chidamide Plus R-CHOP in Elderly DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05233124 | Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT00610792 | Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT03553537 | Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03047837 | A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients. | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
| NCT00550771 | German Preoperative Adriamycin Docetaxel Study | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00169130 | ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00446030 | Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT03459560 | Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT04776525 | Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT04403568 | Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate | prostate cancer | Ursolic Acid (NPC51700) | NP level |
| NCT01313702 | Single Pill to Avert Cardiovascular Events | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT00502411 | Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00140595 | ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT04535804 | Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm Delivery | endometriosis of uterus | Aspirin (NPC311219) | NP level |
| NCT02606305 | Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer | fallopian tube cancer;ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00669877 | Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma | Burkitts lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02783599 | A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02960126 | Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) | atrial fibrillation | Aspirin (NPC311219) | NP level |
| NCT01431053 | Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer | breast neoplasm | Aspirin (NPC311219) | NP level |
| NCT02861222 | Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma | malignant glioma | Doxorubicin (NPC261012) | NP level |
| NCT01381211 | Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT01855750 | A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00557921 | Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) | Gastrointestinal hemorrhage | Aspirin (NPC311219) | NP level |
| NCT01646034 | High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00907348 | Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01481194 | ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT01394354 | Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma (MM) | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00206466 | Biologic Correlative Taxotere/AC | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00003389 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00903630 | Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Doxorubicin (NPC261012) | NP level |
| NCT04012827 | Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03517449 | Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) | endometrial neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02348203 | Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers | nicotine dependence | Aspirin (NPC311219) | NP level |
| NCT03004833 | Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma | classic Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02545933 | Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor | myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT00441168 | Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00920153 | Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05113251 | Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03794596 | A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer | breast cancer | Aspirin (NPC311219) | NP level |
| NCT02890602 | Erythropoietin for Management of Anemia Caused by Chemotherapy | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00148681 | Preoperative Herceptin and Navelbine for Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00038558 | Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01379989 | INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT02359162 | Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02475772 | A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT03617432 | Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients | neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02471820 | Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00634205 | Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma | mesothelioma | Doxorubicin (NPC261012) | NP level |
| NCT00265031 | HD12 for Advanced Stages | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00536393 | Treatment of Disseminated High Grade Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00697021 | Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance | myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT00814541 | PAD. ICORG 05-01, V11 | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT03317457 | Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01966471 | A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01148446 | R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03023124 | Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor | neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00000469 | Asymptomatic Carotid Artery Plaque Study (ACAPS) | heart disease;internal carotid artery stenosis;cerebral atherosclerosis | Aspirin (NPC311219) | NP level |
| NCT04745949 | PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy | neoplasm of mature B-cells | Doxorubicin (NPC261012) | NP level |
| NCT04379999 | Atorvastatin ± Aspirin in Lynch Syndrome Syndrome | Lynch syndrome | Aspirin (NPC311219) | NP level |
| NCT01000285 | EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma | T-cell acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT02677116 | A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer | metastasis | Doxorubicin (NPC261012) | NP level |
| NCT01227408 | Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03719430 | APX005M and Doxorubicin in Advanced Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00109837 | S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Doxorubicin (NPC261012) | NP level |
| NCT01415765 | MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00731302 | Aspirin Resistance in Systemic Lupus Erythematosus (SLE) | systemic lupus erythematosus | Aspirin (NPC311219) | NP level |
| NCT00636441 | Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02431559 | Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00054665 | PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma | neoplasm of mature B-cells | Doxorubicin (NPC261012) | NP level |
| NCT02834403 | L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients | breast cancer | Aspirin (NPC311219) | NP level |
| NCT04243616 | Cemiplimab in High Risk or Locally Advanced Hormone Receptor Positive HER2 Negative or Triple-Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00131027 | High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00003352 | Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03820466 | Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin | acute chest syndrome | Aspirin (NPC311219) | NP level |
| NCT00801580 | My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia | lymphoid leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00890656 | Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT01354522 | TAC Versus TCX as Adjuvant Treatment for Node-Positive Her2-Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03742986 | Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC) | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00102219 | A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00002707 | Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04729387 | Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT02174328 | Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes. | preeclampsia | Aspirin (NPC311219) | NP level |
| NCT04243278 | Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC) | preeclampsia | Aspirin (NPC311219) | NP level |
| NCT01864109 | Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma | Ewing sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT05112536 | Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00021255 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00653172 | Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia | pneumonia | Aspirin (NPC311219) | NP level |
| NCT03536039 | RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03669783 | Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm) | childhood kidney neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00718484 | A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT04142125 | Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT03033914 | A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04410328 | Aggrenox To Treat Acute Covid-19 | COVID-19 | Aspirin (NPC311219) | NP level |
| NCT01784159 | ASpirin for Patients With SEPsis and SeptIc Shock | Sepsis | Aspirin (NPC311219) | NP level |
| NCT03808480 | Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10% | non-small cell lung carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02072226 | A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke | stroke | Aspirin (NPC311219) | NP level |
| NCT05008224 | Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) | classic Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02451943 | A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02631109 | L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis | hemophagocytic syndrome | Doxorubicin (NPC261012) | NP level |
| NCT00628251 | Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer | ovarian neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT01486433 | The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects | Hypertriglyceridemia | Aspirin (NPC311219) | NP level |
| NCT04660799 | A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02323516 | Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies. | cancer | Aspirin (NPC311219) | NP level |
| NCT01070862 | Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies. | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT01515657 | Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
| NCT00484601 | Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02661503 | HD21 for Advanced Stages | classic Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01812369 | Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer | urinary bladder cancer | Doxorubicin (NPC261012) | NP level |
| NCT03056001 | Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00187161 | Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT02012088 | Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01004991 | Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00455897 | CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00931918 | Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03219645 | Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT02850419 | Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02008942 | Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
| NCT00506155 | Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer | urinary bladder cancer | Doxorubicin (NPC261012) | NP level |
| NCT00366106 | Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT00002557 | Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01404936 | Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01104298 | Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03487406 | Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2) | chronic obstructive pulmonary disease | Aspirin (NPC311219) | NP level |
| NCT00575406 | Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01148628 | Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors | neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT03853044 | Study Evaluating the Safety and Efficacy of C-CHOP in Untreated Subjects With Angioimmunoblastic T Cell Lymphoma | angioimmunoblastic T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05498896 | Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00290498 | Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00578864 | Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma | neuroblastoma | Doxorubicin (NPC261012) | NP level |
| NCT01593020 | Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00542191 | Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00145002 | A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) | adult T-cell leukemia/lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01251107 | Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04685616 | Brentuximab Vedotin in Early Stage Hodgkin Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00797056 | Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease | peripheral vascular disease | Aspirin (NPC311219) | NP level |
| NCT00314977 | Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer. | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01016054 | A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00148317 | Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT02499367 | Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00578721 | Trial of Aspirin and Arginine Restriction in Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT03093207 | Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis | periodontitis | Aspirin (NPC311219) | NP level |
| NCT00877071 | LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT04535518 | Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease | mucocutaneous lymph node syndrome | Aspirin (NPC311219) | NP level |
| NCT00963443 | Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold | common cold | Aspirin (NPC311219) | NP level |
| NCT01120171 | Myocet Plus Endoxan for Older Patients With Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00183742 | Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere) | carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT03994107 | Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01818063 | Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer | triple-negative breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03197935 | A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer | triple-negative breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00562588 | EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA | stroke | Aspirin (NPC311219) | NP level |
| NCT03485118 | RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05201248 | A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma | neoplasm of mature B-cells | Doxorubicin (NPC261012) | NP level |
| NCT00017160 | Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00144807 | ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00174707 | Study of Docetaxel in Breast Cancer Patients | breast neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00355199 | Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL. | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00426127 | Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02784015 | Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03197779 | A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects | thrombotic disease | Aspirin (NPC311219) | NP level |
| NCT04540692 | Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00944047 | Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03003325 | The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV | polycythemia vera | Aspirin (NPC311219) | NP level |
| NCT00973752 | Treatment of Older Adults With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00770224 | S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00007683 | Warfarin and Antiplatelet Therapy in Chronic Heart Failure | heart failure | Aspirin (NPC311219) | NP level |
| NCT02177695 | S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer | urinary bladder cancer | Doxorubicin (NPC261012) | NP level |
| NCT00030381 | Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis | primary systemic amyloidosis | Doxorubicin (NPC261012) | NP level |
| NCT03335241 | Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT04884035 | Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00146562 | Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01992653 | A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01936233 | Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery | hepatocellular carcinoma | Aspirin (NPC311219) | NP level |
| NCT00179725 | Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00288431 | Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015) | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02527772 | Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT04301739 | to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC) | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00563953 | Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02822157 | Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer | malignant epithelial tumor of ovary | Doxorubicin (NPC261012) | NP level |
| NCT00003421 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04546620 | Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03329378 | Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02301286 | A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
| NCT01777152 | ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00041132 | S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02227368 | Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR | peripheral arterial disease | Aspirin (NPC311219) | NP level |
| NCT00001384 | A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00417898 | Study of Aspirin and TPA in Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT02560051 | Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer | prostate adenocarcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00060385 | Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02927249 | Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy | breast cancer | Aspirin (NPC311219) | NP level |
| NCT00335452 | Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT04070573 | Low Doses of Aspirin in the Prevention of Preeclampsia | preeclampsia | Aspirin (NPC311219) | NP level |
| NCT01176799 | Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00136565 | Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma | unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00814268 | COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke | stroke | Aspirin (NPC311219) | NP level |
| NCT03677141 | A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma | neoplasm of mature B-cells | Doxorubicin (NPC261012) | NP level |
| NCT02096588 | Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00083551 | UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT02677545 | Ticagrelor Versus Clopidogrel in Carotid Artery Stenting | internal carotid artery stenosis | Aspirin (NPC311219) | NP level |
| NCT01440088 | A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT05456022 | Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line | mouth neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00149214 | Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00483509 | Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma | small cell lung carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT05389423 | Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas | Burkitts lymphoma;diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00064116 | Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00002318 | A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma | Kaposi's sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01523977 | Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00796120 | An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS) | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02155985 | Modulation of Immune Activation by Aspirin | HIV-1 infection | Aspirin (NPC311219) | NP level |
| NCT04047004 | Adjuvant PIPAC in Gastric Cancer Patients | gastric adenocarcinoma | Doxorubicin (NPC261012) | NP level |
| NCT03152409 | Salicylic Augmentation in Depression | major depressive disorder;treatment resistant depression | Aspirin (NPC311219) | NP level |
| NCT02372409 | Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors | anaplastic astrocytoma;glioblastoma multiforme;oligoastrocytoma;oligodendroglioma;optic nerve glioblastoma;pilocytic astrocytoma | Doxorubicin (NPC261012) | NP level |
| NCT02419755 | Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies | acute leukemia of ambiguous lineage;acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT04213794 | Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for the Treatment of Resectable, Refractory, or Recurrent Abdominal or Pelvic Tumors in Pediatric Patients, T.O.A.S.T. I.T. Study | rhabdomyosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT04908787 | A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT02790580 | Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00005800 | Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03786783 | Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | ganglioneuroblastoma;neuroblastoma | Doxorubicin (NPC261012) | NP level |
| NCT05075460 | Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00504504 | Rituximab and ABVD for Hodgkin's Patients | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00586846 | Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma | osteosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT02685748 | Aspirin in Young Psychotic Patients | schizophrenia | Aspirin (NPC311219) | NP level |
| NCT01248468 | Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine | migraine disorder | Aspirin (NPC311219) | NP level |
| NCT03817320 | PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04182100 | Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply | polycythemia vera | Aspirin (NPC311219) | NP level |
| NCT01659099 | GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02120092 | The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man | acute coronary syndrome | Aspirin (NPC311219) | NP level |
| NCT01210768 | A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00000500 | Physicians' Health Study | Myocardial Ischemia | Aspirin (NPC311219) | NP level |
| NCT01051778 | Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome | habitual abortion | Aspirin (NPC311219) | NP level |
| NCT04478292 | A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy | Hepatoblastoma | Doxorubicin (NPC261012) | NP level |
| NCT04535713 | GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00027066 | Warfarin Versus Aspirin Recurrent Stroke Study | stroke | Aspirin (NPC311219) | NP level |
| NCT00083538 | Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | multiple myeloma | Doxorubicin (NPC261012) | NP level |
| NCT03294577 | Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia | neutropenia | Doxorubicin (NPC261012) | NP level |
| NCT00202020 | Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke | cerebral infarction | Aspirin (NPC311219) | NP level |
| NCT00052936 | Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01719835 | CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study | anaplastic large cell lymphoma;angioimmunoblastic T-cell lymphoma;unspecified peripheral T-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02751918 | Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer | ovarian neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02247869 | Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma | Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00793377 | Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01733485 | Electrophilic Fatty Acid Derivatives in Asthma | asthma | Aspirin (NPC311219) | NP level |
| NCT01414855 | A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00913835 | A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer | ovarian neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00401817 | Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02812654 | Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03661411 | Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke | stroke | Aspirin (NPC311219) | NP level |
| NCT03957902 | Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
| NCT03340376 | Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer | cervical cancer | Doxorubicin (NPC261012) | NP level |
| NCT02414568 | Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin | classic Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04307576 | A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT04284397 | Identification of Critical Thermal Environments for Aged Adults | aging | Aspirin (NPC311219) | NP level |
| NCT01784120 | A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00003541 | Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01319981 | Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia | leukemia | Doxorubicin (NPC261012) | NP level |
| NCT03639246 | Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00721747 | Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03420014 | Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) | leiomyosarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01027910 | PCI-24781 in Combination With Doxorubicin to Treat Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00960869 | Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers | gastric ulcer | Aspirin (NPC311219) | NP level |
| NCT04322318 | A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT | kidney Wilms tumor | Doxorubicin (NPC261012) | NP level |
| NCT01014767 | Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | brain cancer;choroid plexus neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00425074 | Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism. | cardiovascular disease | Aspirin (NPC311219) | NP level |
| NCT02449265 | Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05177796 | Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer | breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00001498 | A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04835870 | Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03539328 | Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT02377752 | A Study of Olaratumab in Japanese Participants With Advanced Cancer | neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT00448266 | Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00484341 | Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas. | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03515200 | Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT03301350 | Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT05428072 | Alcohol, Gut Leakiness, & Liver Disease | alcoholic liver disease | Aspirin (NPC311219) | NP level |
| NCT01259856 | Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) | essential thrombocythemia;polycythemia vera | Aspirin (NPC311219) | NP level |
| NCT04594798 | A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02433587 | Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization | peripheral arterial disease | Aspirin (NPC311219) | NP level |
| NCT01090128 | Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00055731 | Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse | prostate cancer | Aspirin (NPC311219) | NP level |
| NCT01800357 | Efficacy and Safety of Mildronate for Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
| NCT02215876 | Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT03571321 | Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT00776477 | The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease | atherosclerosis | Aspirin (NPC311219) | NP level |
| NCT05404945 | Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above | classic Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02845882 | LBL-2016 for Children or Adolescents in China | lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00494780 | Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01678664 | Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors | neuroendocrine neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT02994251 | A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma | cholangiocarcinoma | Doxorubicin (NPC261012) | NP level |
| NCT02506777 | Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT01012349 | Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache. | Tension-type headache | Aspirin (NPC311219) | NP level |
| NCT00659178 | Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer | ovarian neoplasm | Doxorubicin (NPC261012) | NP level |
| NCT03129828 | Ibrutinib, Bortezomib and Rituximab-CHOP for the Treatment of Elderly Patients With CD20+ DLBCL, IPI ≥ 2 | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00133302 | Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809) | non-Hodgkins lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01362218 | Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol | Hypercholesterolemia | Aspirin (NPC311219) | NP level |
| NCT00433433 | Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma | lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02494713 | Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer | prostate cancer | Doxorubicin (NPC261012) | NP level |
| NCT02007837 | Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial | preeclampsia | Aspirin (NPC311219) | NP level |
| NCT00775762 | Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events | vascular disease | Aspirin (NPC311219) | NP level |
| NCT01670500 | Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT00022945 | Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma | Mantle cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT05058404 | Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT03527628 | OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy | classic Hodgkin lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT01633528 | The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy | infertility | Aspirin (NPC311219) | NP level |
| NCT01741922 | Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients | hypertension | Aspirin (NPC311219) | NP level |
| NCT00000161 | Randomized Trials of Vitamin Supplements and Eye Disease | cataract;macular degeneration | Aspirin (NPC311219) | NP level |
| NCT00886028 | Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma | malignant pleural mesothelioma | Doxorubicin (NPC261012) | NP level |
| NCT03971409 | Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer | breast carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT04526951 | TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) | retinal artery occlusion | Aspirin (NPC311219) | NP level |
| NCT03192644 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT00404066 | Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04002947 | Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00135135 | Therapy for Children With Neuroblastoma | neuroblastoma | Doxorubicin (NPC261012) | NP level |
| NCT00755261 | Phase II Study of Doxorubicin and Avastin® in Sarcoma. | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03541109 | A Polypill for Secondary Prevention of Ischemic Heart Disease | Non-ST Elevation Myocardial Infarction;ST Elevation Myocardial Infarction;acute myocardial infarction | Aspirin (NPC311219) | NP level |
| NCT03399747 | Abbreviated 3 Cycles of Rituximab Plus CHOP(Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients With Completely Excised LocalizedGastrointestinal CD(Cluster of Differentiation Antigen)20(+) Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT02341638 | Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects | thrombotic disease | Aspirin (NPC311219) | NP level |
| NCT03283696 | A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT03543683 | Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
| NCT02420717 | Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT03667326 | Postpartum Low-Dose Aspirin and Preeclampsia | preeclampsia | Aspirin (NPC311219) | NP level |
| NCT05453500 | Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Doxorubicin (NPC261012) | NP level |
| NCT03059615 | A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS | acute myeloid leukemia;myelodysplastic syndrome | Doxorubicin (NPC261012) | NP level |
| NCT01830543 | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039 | atrial fibrillation | Aspirin (NPC311219) | NP level |
| NCT03093246 | Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis | periodontitis | Aspirin (NPC311219) | NP level |
| NCT04188119 | A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer | breast cancer | Aspirin (NPC311219) | NP level |
| NCT03991884 | Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia;lymphoblastic lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT04745832 | Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
| NCT00861120 | Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type | ovarian cancer | Doxorubicin (NPC261012) | NP level |
| NCT00256243 | Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT02255110 | A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma | soft tissue sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT01116635 | Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Doxorubicin (NPC261012) | NP level |
| NCT03425656 | Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer | breast cancer | Doxorubicin (NPC261012) | NP level |
| NCT04199026 | Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma | sarcoma | Doxorubicin (NPC261012) | NP level |
| NCT00774826 | Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma | follicular lymphoma | Doxorubicin (NPC261012) | NP level |
❱❱❱ Associated Human Diseases and Detailed Association Evidence
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
|---|---|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
TOP2A,FLT3
NCT02734771,NCT01148446,NCT05018520,NCT04025593,NCT03274492,NCT04660799,NCT00850512,NCT04974996,NCT04517435,NCT02449278,NCT05422066,NCT01659099,NCT01459887,NCT02855359,NCT01804127,NCT01724021,NCT03003520,NCT00582725,NCT02428751,NCT03758989,NCT02228512,NCT00931918,NCT00379574,NCT02889523,NCT05234684,NCT02054559,NCT05406401,NCT00140595,NCT03018626,NCT00169130,NCT02449265,NCT01087424,NCT05200312,NCT01415765,NCT04332822,NCT00499018,NCT03201471,NCT03536039,NCT03485118,NCT01649856,NCT05290090,NCT02867566,NCT03129828,NCT03943901,NCT01848132,NCT04546620,NCT01852435,NCT00135499,NCT02753647,NCT01287741,NCT05351346,NCT04835870,NCT05389423,NCT02617485,NCT05179733,NCT03399747,NCT04139304,NCT02792491,NCT04231448,NCT04824092,NCT02531308,NCT02772822,NCT01009970,NCT02951728,NCT04790903,NCT01925612,NCT02285062,NCT02733380,NCT05498259,NCT00355199,NCT05189197,NCT01622439,NCT00268853,NCT00575406,NCT03225924,NCT02890602,NCT03650933,NCT01004991,NCT04594798,NCT01285765,NCT04002947,NCT04023916,NCT01040871,NCT02596971,NCT05428670,NCT04529772,NCT04661007,NCT04263584,NCT04021992,NCT00144807 |
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
PTGS1,RELA,NFKB1,DPP4
NCT02008942,NCT01515657,NCT03341117,NCT05105919,NCT02164578 |
Neuroblastoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH85Z0 |
NCT00135135,NCT01857934,NCT01704716,NCT04221035,NCT00578864,NCT02771743,NCT03786783,NCT00186849,NCT00808899
|
Classical Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30.1 |
NCT02661503,NCT03004833,NCT03233347,NCT03712202,NCT03527628,NCT04624984,NCT05404945,NCT02414568,NCT05008224
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT01455532,NCT01214668,NCT03617432,NCT02377752,NCT01702129,NCT00819221,NCT03023124,NCT01148628,NCT02602938
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
RORC,MMP12,SNCA,XDH,NOX4,BLM,CA4,EPAS1,PTGS1
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
CSNK2A3,CYP1B1,CA9,BLM,CA12,DPP4,TSHR,PTGS1,LMNA
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
MKNK1,CA9,TOP2A,HIF1A,MKNK2,MTOR
NCT01490047,NCT00217425,NCT00005584,NCT00577629,NCT00041210,NCT02359162,NCT00003215,NCT03188198,NCT01118026,NCT00003389,NCT00450801,NCT00290498,NCT00577993,NCT01889069,NCT00003595,NCT00450385,NCT00004179,NCT01516567,NCT04980222,NCT00369681,NCT00920153,NCT00822120,NCT01855750,NCT00002557,NCT00841945,NCT00211185,NCT00064116,NCT00770224,NCT00004031,NCT00003541,NCT00536393,NCT00210379,NCT01414855,NCT00002565,NCT03647072,NCT00854568,NCT01139359,NCT00893516,NCT00101101,NCT00299182,NCT00003784,NCT00060346,NCT00265031,NCT01321008,NCT01404936,NCT00911183,NCT00554164,NCT05075460,NCT01527422,NCT02670317,NCT04164368,NCT00264953,NCT00265018,NCT05006664,NCT01974440,NCT00787527,NCT00504504,NCT00060385,NCT00003150,NCT00004112,NCT01046825,NCT02529852,NCT00433433,NCT02918747,NCT04884035,NCT00006721,NCT00049595,NCT00451178,NCT00041132,NCT00003578,NCT02605694,NCT00004010,NCT03975205,NCT00945724,NCT01390584,NCT01992653,NCT00052936,NCT00118209,NCT01831505,NCT00003421,NCT00974324,NCT02012088,NCT00005867 |
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
TOP2A,RORC,FLT3,RELA,AHR,DPP4,NFKB1
MMP12 |
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
AURKA,NFKB1,GSK3B,TOP2A,RELA,FLT3
NCT03860844,NCT03059615 |
Chronic arterial occlusive disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
NCT05308030,NCT00797056,NCT01802775,NCT02798913,NCT02217501,NCT02433587,NCT02227368,NCT02770274
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
NCT00903630,NCT02865811,NCT00262990,NCT01100372,NCT02606305,NCT01666444,NCT00189553,NCT00003896
|
LeukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60-2B33 |
NCT00109837,NCT01516580,NCT03975205,NCT00072007,NCT01319981,NCT02723994,NCT00038610,NCT00613457
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
MMP12,ALPL,AKR1B1,NOX4,BLM,DPP4,TSHR,FLT3
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
AURKA,AKR1B1,DHCR7,CA9,BLM,TOP2A,CYP2C9,CYP1A2
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
MMP12,CYP1B1,ALPL,NOX4,CA12,DPP4,XDH,CA7
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
MTOR,HIF1A
NCT01741922,NCT01880866,NCT00384865,NCT00223717,NCT00105209 |
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT03543683,NCT02387086,NCT03532698,NCT01058902,NCT02419495,NCT04224337,NCT03808480
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
CA7
NCT00496769,NCT02960126,NCT00244426,NCT00623779,NCT01830543,NCT02164864 |
Deep vein thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD71 |
NCT01046942,NCT03197779,NCT02341638,NCT02984384,NCT02671461,NCT02846532,NCT02439190
|
LeiomyosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B58 |
NCT03420014,NCT02131480,NCT05099666,NCT03437070,NCT00815945,NCT02997358,NCT04996004
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
MMP12,THPO,AURKA,CA9,BLM,CA12,TOP2A
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
MTOR
NCT03192059,NCT00883116,NCT00401635,NCT01767155,NCT01100359 |
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
GSK3B
NCT01258634,NCT00145639,NCT00691236,NCT00586846,NCT00180908 |
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
EPAS1,MMP12,MTOR,CA9
NCT00068393,NCT02419495 |
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
MTOR,TOP2A,FLT3,AURKA,DPP4
NCT00051311 |
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
MTOR,FLT3,RORC,AURKA,MMP12,TOP2A
|
NADisease Category: NADisease ICD-11 Code: NA |
NOX4
NCT02813824,NCT04379999,NCT02497820,NCT01762787,NCT03377543 |
Cerebral ischaemic stroke, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11.5Z |
NCT03186456,NCT00004728,NCT00684515,NCT00129805,NCT00202020,NCT03176498
|
Malignant neoplasms of bladder, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.Z |
NCT01812369,NCT00635726,NCT04101812,NCT02177695,NCT00808639,NCT00506155
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
MMP12,AURKA,NOX4,BLM,TOP2A
NCT04047004 |
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
MMP12,AURKA,CA9,CA12,TOP2A,XDH
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CYP1A2,CA12,AURKA,DHCR7,CYP1A1,TOP2A
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
FLT3,TOP2A
NCT02431559,NCT04887961,NCT03161132,NCT00179725,NCT00189553,NCT03335241,NCT00758732,NCT01100372,NCT03378297,NCT04729387,NCT01379989,NCT03639246,NCT01388621,NCT00610792,NCT02475772,NCT00523380,NCT02421588,NCT01802749,NCT02606305,NCT05467670,NCT03596281,NCT03539328,NCT02865811,NCT01696032,NCT00976911,NCT00861120,NCT04348032,NCT00262990,NCT00657878,NCT03480776,NCT01113957,NCT01705158,NCT00484432,NCT03699449,NCT01666444,NCT00722592,NCT00635193,NCT00003896,NCT02098343,NCT01227941,NCT04908787,NCT01358071,NCT01016054,NCT03804866,NCT01637532,NCT01809379,NCT00326456,NCT04679064,NCT00903630,NCT03467178 |
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
TOP2A,RORC,NFKB1,RELA
NCT03824938 |
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
NFKB1,DPP4,RELA
NCT03574909,NCT02895113 |
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
TOP2A,CA4,MMP12
NCT01733485,NCT02906761 |
Kaposi sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B57 |
TOP2A
NCT00002105,NCT00002318,NCT02659930,NCT00923936 |
Asymptomatic stenosis of intracranial or extracranial arteryDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD55 |
NCT02689037,NCT00000469,NCT00000527,NCT00000469,NCT02677545
|
Carcinomas of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.0 |
NCT03598270,NCT03542669,NCT02419495,NCT02107378,NCT00312650
|
Migraine disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SD10 |
NCT01248468,NCT02183220,NCT01629329,NCT01973205,NCT02183688
|
Ischaemic heart diseases, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA6Z |
NCT00000500,NCT00000496,NCT00000491,NCT00000479,NCT00000510
|
Venous thromboembolismDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD72 |
NCT02271399,NCT01720108,NCT04153760,NCT04295486,NCT04368377
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT03464305,NCT03047837,NCT05036109,NCT02467582,NCT02301286
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
CYP1A1,EPAS1,F3
NCT00731302,NCT00054938 |
Polycythaemia veraDisease Category: X.Extension CodesDisease ICD-11 Code: XH0453 |
NCT01259817,NCT00940784,NCT01259856,NCT03003325,NCT04182100
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
CYP1A1,MMP12,NOX4,CA9,TYR
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
MMP12,AURKA,NOX4,BLM,TOP2A
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
CYP1A1,CYP2C19,THPO,KDM4E,CYP2C9
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
MMP12,NOX4,BLM,PTGS1,AHR
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
AHR,FLT3,MTOR
NCT00003853,NCT00925821,NCT00572169,NCT03428373,NCT00706953,NCT01215344,NCT01492881,NCT01481194,NCT02471820,NCT02362165,NCT00516191,NCT00814541,NCT00617591,NCT00215943,NCT01042704,NCT00750815,NCT00734877,NCT00574080,NCT01355705,NCT00441168,NCT00083551,NCT01246063,NCT00405756,NCT01548573,NCT00319865,NCT01541332,NCT02186834,NCT04877275,NCT01078441,NCT01070862,NCT00366106,NCT01394354,NCT00083538,NCT00482261,NCT01177683,NCT00833833,NCT01328236,NCT00083915,NCT00258245,NCT00148317,NCT00869232,NCT03004287,NCT01101594,NCT00871013 |
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
RELA,NFKB1,AKR1B1,PTGS1
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
SNCA,TOP2A,FLT3,PTGS1
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
PTGS1,NFKB1,RELA,AHR
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
EPAS1,TOP2A,HIF1A
NCT01014767 |
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
CA12,TOP2A,CA4,CYP2C9
|
Pleural mesotheliomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26 |
MTOR
NCT00634205,NCT00859495,NCT00886028 |
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
NCT04358341,NCT01854255,NCT04214990,NCT05318794
|
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT00001339,NCT01678664,NCT00094497,NCT00183742
|
Burkitt lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4KA9 |
NCT00126191,NCT05270057,NCT00669877,NCT05389423
|
Melanoma of skin, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30.Z |
NCT03396952,NCT04062032,NCT04066725,NCT02419495
|
Ewing sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B52 |
NCT00568464,NCT01864109,NCT02063022,NCT00038142
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT00944801,NCT02372409,NCT01851733,NCT00790452
|
Angioimmunoblastic T-cell lymphomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1J86 |
NCT00169156,NCT00725231,NCT01719835,NCT03853044
|
Neoplasms of unknown behaviour of urinary organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F98 |
NCT04506554,NCT03669783,NCT02710734,NCT04383743
|
Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associatedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.5 |
NCT01788137,NCT02228772,NCT01000285,NCT03007147
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT02865811,NCT00903630,NCT00003896,NCT01100372
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
ALPL,CA12,TOP2A,HSD17B2
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
MMP12,AURKA,NOX4,CA9
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
DPP4,SNCA,LMNA,CA4
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
HIF1A,XDH,F3,LMNA
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
THPO,CYP1B1,NOX4,DPP4
|
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT02419755,NCT05453500,NCT03991884,NCT00968253,NCT03117751,NCT03860844,NCT01186328,NCT01324180,NCT01887587,NCT00165087,NCT00136435,NCT03817320,NCT03023046,NCT00973752,NCT03515200,NCT04996160,NCT00549848,NCT00600977,NCT00137111,NCT00890656,NCT02881086,NCT00187161,NCT02420717,NCT00131027,NCT03643276,NCT00439296,NCT00440726,NCT00165178,NCT00671658,NCT04307576,NCT03150693,NCT01523977,NCT03020030,NCT05303792,NCT00476190,NCT03571321,NCT03553238,NCT03384654,NCT03349281
|
Soft tissue disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB56 |
NCT00790244,NCT05448820,NCT04765228,NCT00755261,NCT04910126,NCT04012827,NCT00017160,NCT04032964,NCT04757337,NCT03805022,NCT01861951,NCT02255110,NCT05100628,NCT00102609,NCT01168791,NCT02451943,NCT02783599,NCT00484341,NCT03283696,NCT01514188,NCT03108300,NCT02049905,NCT00718484,NCT02784015,NCT04656262,NCT03719430,NCT00626704,NCT00878800,NCT04874311,NCT01440088,NCT03056001,NCT03698227,NCT04780464,NCT04776525,NCT03317457,NCT04650984,NCT00502411,NCT03042819
|
Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30 |
NCT00797472,NCT02979522,NCT01356680,NCT02505269,NCT03517137,NCT04685616,NCT01251107,NCT00795613,NCT02275598,NCT00443677,NCT01652261,NCT01056679,NCT03407144,NCT00026208,NCT00512980,NCT00816959,NCT02398240,NCT00038558,NCT02181738,NCT00784537,NCT02292979,NCT03618550,NCT02247869,NCT01468740,NCT00736320,NCT03033914,NCT01358747,NCT01920932,NCT03159897,NCT03755804,NCT03646123,NCT01060904,NCT01712490,NCT00225173,NCT02298283,NCT04638790,NCT01569204
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
AKR1B1
NCT00000157,NCT00000161 |
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
PTGS1,GSK3B,SNCA
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
MTOR,TOP2A,F3
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
NFKB1,RELA,PTGS1
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA12,CA4,PTGS1
|
Acute respiratory distress syndromeDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB00 |
F3
NCT01504867,NCT02326350 |
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
TOP2A,PTGS1
NCT04575519 |
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
AURKA,AKR1B1,DPP4
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
PTGS1,NFKB1,RELA
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
AKR1B1
NCT02685748,NCT01320982 |
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
RORC
MMP12,ALPL |
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
XDH
NCT01709994,NCT01768637 |
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
FLT3
NCT01279291,NCT00262990 |
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
AKR1B1,TOP2A
NCT04128956 |
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
DPP4
NCT00300365,NCT02337933 |
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
AHR
NCT01259817,NCT01259856 |
Rhabdomyosarcoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0GA1 |
NCT01871766,NCT04625907,NCT04213794
|
Human immunodeficiency virus type 1Disease Category: X.Extension CodesDisease ICD-11 Code: XN8LD |
NCT02578706,NCT02155985,NCT01426438
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
NCT01755520,NCT01103440,NCT00000510
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
NCT04229264,NCT02260622,NCT01211925
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
NOX4
NCT03899987,NCT02560051 |
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT03316534,NCT02081638,NCT00783614
|
Inflammatory carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C62 |
NCT02623972,NCT02876302,NCT02125344
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT00426127,NCT00609765,NCT04203641
|
Other specified infectious meningitis not elsewhere classifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D01.Y |
NCT04145258,NCT02237365,NCT03927313
|
Haemorrhage, not elsewhere classifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG27 |
NCT00405613,NCT03787927,NCT02966119
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
NCT01797575,NCT05035316,NCT01429272
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
NCT00004728,NCT01526122,NCT00776477
|
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT02677116,NCT02419495,NCT03678883
|
Small cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.1 |
NCT02261805,NCT00483509,NCT02566993
|
Peptic ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA61 |
NCT01015729,NCT00175032,NCT00998075
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
NCT03487406,NCT05265299,NCT01328145
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
MMP12,ALPL,NOX4
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
RORC,CA4,F3
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
MMP12,CYP1A1,CA9
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
THPO
NCT02313909,NCT02666742,NCT00814268,NCT01661322,NCT04962451,NCT02427126,NCT00004728,NCT02776540,NCT04824911,NCT03578822,NCT01518231,NCT00562588,NCT00004727,NCT03661411,NCT00059306,NCT00311402,NCT01994720,NCT04330872,NCT03192215,NCT00238667,NCT00276380,NCT03961334,NCT02224131,NCT00027066,NCT00041938,NCT02239120,NCT02072226 |
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
MTOR
NCT02326025,NCT05210374,NCT04968106,NCT02812654,NCT03802071,NCT00796120,NCT00204568,NCT03678883,NCT00189137,NCT01027910,NCT00001300,NCT00204646,NCT01104298,NCT03880695,NCT00288431,NCT01185964,NCT04199026,NCT01746238,NCT02732015,NCT02448537,NCT00949325,NCT04535713,NCT01605526 |
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT00990860,NCT02958163,NCT05093920,NCT01381211,NCT01004978,NCT00083226,NCT03937830,NCT01281943,NCT02527772,NCT03192644,NCT00471965,NCT01840592,NCT00108953,NCT00057382,NCT00877071,NCT01655693,NCT01936233,NCT01966133,NCT00988195,NCT01858207,NCT01327521,NCT03145558,NCT01116635
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT00455897,NCT00361621,NCT01332968,NCT00193440,NCT02406092,NCT05238064,NCT02626455,NCT01200758,NCT00809341,NCT03571308,NCT00324467,NCT00825149,NCT00184002,NCT00323323,NCT00133302,NCT01516580,NCT01777152,NCT03467373,NCT02055820,NCT00201318,NCT01746173,NCT00719472
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT03036488,NCT00722293,NCT00525642,NCT02622074,NCT00174655,NCT00263211,NCT00121992,NCT00446030,NCT00849472,NCT00429299,NCT00021255,NCT01779050,NCT01431053,NCT00779129,NCT04895358,NCT03678883,NCT00687440,NCT00194753,NCT00550771,NCT01220128,NCT00543829,NCT00174707
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
HIF1A,CA9,GSK3B,CA12,TOP2A,NFKB1,AURKA,CA4,FLT3,AHR,CSNK2A1,RORC,PTGS1,MTOR,RELA,XDH,MKNK1,EPAS1,MKNK2,F3
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
PTGS1
NOX4 |
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
CES1,PTGS1
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
NFKB1,RELA
|
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN2,SMN1
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
NFKB1,RELA
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TOP2A,MTOR
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
CES1,DPP4
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
GSK3B,FLT3
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
NFKB1,RELA
|
Adrenomedullary hyperfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A75 |
EPAS1,HIF1A
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CYP2D6
NCT02268565 |
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
PTGS1,TOP2A
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
RELA,NFKB1
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
AKR1B1,CA4
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR
NCT01882816 |
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
RELA,NFKB1
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
XDH
NCT00007683 |
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
AKR1B1,PTGS1
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
PTGS1
NCT00175032 |
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
AHR
NCT03059615 |
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
PTGS1
NCT00269438 |
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
XDH
NCT02735707 |
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
MTOR,FLT3
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
MTOR
NCT03245489 |
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
NFKB1,RELA
|
Gastric ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA60 |
NCT00961350,NCT00960869
|
Lymphoid leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH7Q12 |
NCT00866749,NCT00801580
|
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT02735707,NCT00653172
|
Venous leg ulcer, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD74.3Z |
NCT02158806,NCT02333123
|
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
NCT00630877,NCT00626392
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NCT02326779,NCT00357682
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
NCT00000469,NCT00000527
|
Anaplastic large cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1LC0 |
NCT01309789,NCT01719835
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT00000152,NCT00000161
|
Malignant neoplasms of nasopharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
NCT00484601,NCT03290820
|
Acute ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.0 |
NCT04754789,NCT03541109
|
Tension-type headacheDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A81 |
NCT01552798,NCT01012349
|
Male infertilityDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB04 |
NCT00644085,NCT01633528
|
Glioma, malignantDisease Category: X.Extension CodesDisease ICD-11 Code: XH4RQ3 |
NCT02861222,NCT03678883
|
Malignant neoplasms of fallopian tube, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74.Z |
NCT02419495,NCT01279291
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT04324463,NCT04381936
|
Periodontal diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0C |
NCT03093246,NCT03093207
|
Mucocutaneous lymph node syndromeDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44.5 |
NCT04078568,NCT04535518
|
Diseases of the digestive system, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
NCT00872534,NCT00688428
|
Retinal artery occlusionsDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B74.0 |
NCT04526951,NCT03197194
|
NeutropeniaDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B00 |
NCT04227990,NCT03294577
|
Cerebral aneurysm, nonrupturedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B22.5 |
NCT03063541,NCT02675205
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
NCT02348203,NCT01796951
|
Common cold disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SA60 |
NCT01033526,NCT00963443
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT01707823,NCT04852367
|
Recurrent pregnancy lossDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA33 |
NCT00959621,NCT01051778
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
NCT03340376,NCT03192059
|
Primary haemophagocytic lymphohistiocytosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01.23 |
NCT04077905,NCT02631109
|
RetinoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D02.2 |
NCT01783535,NCT00186888
|
Becker muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70.0 |
NCT01856868,NCT03236662
|
Acute myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41 |
NCT02929888,NCT03541109
|
Aortic valve stenosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB70 |
NCT05035277,NCT02989558
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
CYP1A1,TSHR
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR,CYP2C9
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
CYP1A1,TOP2A
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
NFKB1,DPP4
|
Pneumonia due to PseudomonasaeruginosaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.05 |
MMP12,DPP4
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
MKNK1,MKNK2,CA4,CA12,MTOR,AURKA,TOP2A,CA9
NCT00563953,NCT03409198,NCT01959490,NCT01358877,NCT00005800,NCT02132949,NCT00524810,NCT02472353,NCT03726879,NCT00004067,NCT00001498,NCT05207514,NCT00346229,NCT01008150,NCT04172259,NCT00336791,NCT02562378,NCT00455533,NCT03575520,NCT04540692,NCT01593020,NCT00203372,NCT00499122,NCT01990352,NCT04498793,NCT04243616,NCT01622361,NCT05088057,NCT00250874,NCT00206466,NCT00365417,NCT00448266,NCT00546156,NCT04038489,NCT00789581,NCT00727948,NCT00404066,NCT03742986,NCT00193037,NCT05498896,NCT01796197,NCT03497702,NCT00394251,NCT01354522,NCT03725059,NCT01057069,NCT02488564,NCT00254592,NCT01227408,NCT00201708,NCT01672671,NCT01966471,NCT00087178,NCT00290732,NCT00123929,NCT02506777,NCT02605915,NCT02641847,NCT01940497,NCT02850419,NCT03071926,NCT00559845,NCT00887536,NCT02938442,NCT00191789,NCT04083963,NCT04762901,NCT03994107,NCT04188119,NCT04664972,NCT01969032,NCT01131364,NCT03329378,NCT02096588,NCT04584112,NCT03498716,NCT01172223,NCT00580333,NCT01670500,NCT03491410,NCT02927249,NCT01784120,NCT00129376,NCT00688740,NCT01998906,NCT02838225,NCT01329627,NCT00912444,NCT01396655,NCT02685657,NCT02499367,NCT00574236,NCT00003782,NCT01204801,NCT02995772,NCT03794596,NCT00258960,NCT00591851,NCT00314977,NCT04159818,NCT01646034,NCT00312208,NCT00793377,NCT00590785,NCT01120171,NCT04443348,NCT00149214,NCT01090128,NCT01333423,NCT01847001,NCT00212082,NCT00193115,NCT00944047,NCT00434031,NCT00530101,NCT04024462,NCT04301739,NCT00691912,NCT03248427,NCT00003165,NCT00024102,NCT00082095,NCT02379585,NCT00003352,NCT01415336,NCT00146562,NCT01547741,NCT00903656,NCT00431795,NCT02299999,NCT00574587,NCT00278109,NCT03301350,NCT00777673,NCT00093795,NCT00303108,NCT01964391,NCT05020860,NCT03412643,NCT05097248,NCT02897700,NCT00542191,NCT00408408,NCT00669773,NCT03493854,NCT02062255,NCT03285607,NCT00016406,NCT02834403,NCT00486668,NCT02790580,NCT02032277,NCT02413320,NCT05346107,NCT01206881,NCT00148681,NCT03949634,NCT00365365,NCT05159193,NCT00102219,NCT00256243,NCT00129389,NCT00206518,NCT02215876,NCT01176799,NCT01669239,NCT00266799,NCT04293393,NCT01270373,NCT03933319,NCT03425656,NCT03595592,NCT00465673,NCT05275777,NCT00001384,NCT02053597,NCT01210768,NCT05112536,NCT03609047,NCT01818063,NCT05113251,NCT01705691,NCT00721747,NCT03197935,NCT05386524,NCT00493870,NCT00136539,NCT00636441,NCT00002707 |
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
CYP1B1,CYP2C9,CA7,NAPRT,CES1,SNCA,XDH,RECQL,BLM,DPP4,HIF1A,AURKA,DHCR7,CISD1,LMNA,HSD17B2,CYP2C19,CA9,PTGS1
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
CSNK2A2,FLT3,CA7,MMP12,SNCA,XDH,RECQL,CA12,DPP4,AURKA,DHCR7,SMN1,TYR,LMNA,HSD17B2,AHR,CA9,TOP2A,PTGS1
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
FLT3,MKNK2,TOP2A,MKNK1,PTGS1
NCT02607072,NCT02647099,NCT00565708,NCT02125409,NCT02965703,NCT03957902,NCT00578721,NCT02945033,NCT05036109,NCT00331786,NCT00062023,NCT00002527,NCT05056896 |
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
HSD17B10,THPO,CSNK2A2,NOX4,RECQL,BLM,CA12,AURKA,AKR1B1,SMN1,TSHR,CISD1,LMNA,AHR,CA9,TOP2A,EPAS1,F3
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
DPP4,PTGS1,THPO
NCT01321255,NCT00915733,NCT00041938,NCT00697021,NCT02545933,NCT02548650,NCT02596126,NCT05122455,NCT01459627,NCT05491200,NCT00000479,NCT00000491,NCT01739556 |
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
TOP2A
NCT02889523,NCT00634179,NCT00907348,NCT00494780,NCT00801281,NCT01476787,NCT00774826,NCT00715208,NCT02449252,NCT04745832,NCT01852435,NCT05058404,NCT05371093,NCT02855359,NCT01650701 |
Peripheral T-cell lymphoma, not otherwise specifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.C |
NCT00136565,NCT03542266,NCT03952572,NCT03023358,NCT04922567,NCT04569032,NCT03553537,NCT00970385,NCT00930605,NCT00725231,NCT04480099,NCT01839097,NCT00791947,NCT01796002,NCT01719835,NCT02445404
|
Mantle cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85.5 |
NCT00878254,NCT00877006,NCT02858258,NCT00401817,NCT00209222,NCT02633137,NCT00477412,NCT01865110,NCT04566887,NCT05051891,NCT00022945,NCT00209209,NCT00722137,NCT02427620,NCT00581776
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
HSD17B10,RORC,MMP12,ALPL,AKR1B1,DHCR7,XDH,CA9,TSHR,DPP4,TOP2A,CISD1,PTGS1,CA7,HSD17B2
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
CSNK2A3,NOX4,CYP1A2,MMP12,CA12,RORC,AURKA,TSHR,CISD1,HSD17B2,AHR,ALPL,CA9,XDH
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
HIF1A,SNCA,AKR1B1,XDH,NOX4,SMN1,BLM,CA12,CYP2C9,DPP4,CA4,HSD17B2,PTGS1,AHR
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
PTGS1
NCT01313702,NCT00501059,NCT00425074,NCT02370680,NCT01245608,NCT01271985,NCT04792723,NCT04588727,NCT00935506,NCT03459560,NCT01057537,NCT01082874 |
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
CYP1A1,MMP12,AURKA,ALPL,CA9,BLM,TOP2A,CYP2C9,CYP2D6,XDH,HSD17B2
NCT03517449,NCT03005015 |
Acute ischaemic heart disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA4Z |
NCT01755520,NCT02034292,NCT01657071,NCT01422109,NCT04240834,NCT02120092,NCT00335452,NCT02293395,NCT01294462,NCT05233124,NCT02419820,NCT00699998,NCT00910065
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
CSNK2A3,NOX4,MMP12,BLM,CA4,HIF1A,AURKA,AKR1B1,LMNA,CA9,TOP2A,PTGS1,F3
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
MMP12,AURKA,NOX4,CA9,BLM,CA12,TOP2A,CA4,MMP12,AURKA,CA9,CA12,TOP2A
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
MMP12,AURKA,SNCA,DHCR7,NOX4,CA9,BLM,CA12,DPP4,TOP2A,CA4,CA7,HSD17B2
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
CSNK2A1,TOP2A,MKNK2,AURKA,MKNK1,MTOR
NCT00956930,NCT01009801,NCT00093444,NCT02753881,NCT01324076,NCT00003907 |
Precursor B-lymphoblastic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A70 |
NCT02228772,NCT03564704,NCT02845882,NCT03023046,NCT03817320,NCT03991884,NCT04043494,NCT00866749,NCT01451515,NCT02881086,NCT05303792,NCT01887587
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04466670,NCT04410328,NCT04368377,NCT04363840,NCT04324463,NCT04937088,NCT04498273,NCT05073718,NCT04343001,NCT04554433,NCT04365309,NCT02735707
|
Cerebral ischaemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11 |
NCT03219645,NCT00417898,NCT04142125,NCT00265408,NCT02071004,NCT01800357,NCT02869009,NCT00061373,NCT01831011,NCT04809818,NCT01790997,NCT01675115
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
MMP12,THPO,AURKA,CA9,BLM,CA12,CYP2C9,TSHR,CYP2D6,TOP2A,XDH,CA7
|
Malignant neoplasms of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
NCT01121406,NCT00913835,NCT00248248,NCT02659384,NCT02751918,NCT00780039,NCT00350948,NCT00659178,NCT01279291,NCT00628251,NCT02903004
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
CA4
NCT04645004,NCT03667326,NCT04402385,NCT04070573,NCT02174328,NCT02007837,NCT04243278,NCT01890005,NCT02301780,NCT02797249 |
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT00703170,NCT00124956,NCT02323516,NCT00305084,NCT00608803,NCT02285738,NCT00798252,NCT00147225,NCT01110603,NCT02483247,NCT00507962
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
HSD17B10,MMP12,NFKB1,CYP1B1,AKR1B1,CA9,DPP4,CYP2C9,CISD1,FLT3,HSD17B2
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
TOP2A,FLT3
NCT03467373,NCT00324467,NCT02787239,NCT00486759,NCT04745949,NCT03677141,NCT00054665,NCT05201248 |
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
AKR1B1,PTGS1,MTOR
NCT04860804,NCT05156879,NCT04860713,NCT03225352,NCT00261586,NCT00631111,NCT03056703 |
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
MTOR,AURKA
NCT03819101,NCT01240629,NCT04403568,NCT03103152,NCT00176293,NCT00316927,NCT00055731,NCT02494713 |
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
MMP12,AURKA,AKR1B1,NOX4,BLM,CA12,TOP2A,CA4
NCT04478292,NCT03017326 |
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
NCT03164993,NCT01498588,NCT03971409,NCT04081389,NCT01275677,NCT03101748,NCT02419495,NCT01935492,NCT05177796,NCT01885013
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
XDH,CA9,TOP2A,CYP2C9,TYR,MMP12,CA9,TSHR,TOP2A
NCT04322318 |
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
MMP12,AURKA,CA7,CA9,BLM,CA12,CYP2C9,TSHR,TOP2A,XDH
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
DPP4
|
Acquired hypomelanotic disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED63 |
TYR
|
LymphangioleiomyomatosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB07 |
MTOR
|
Phakomatoses/hamartoneoplastic syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2D |
FLT3
|
Inflammatory arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA2Z |
FLT3
|
Arteries/arterioles disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD52 |
MTOR
|
Eye anterior segment structural developmental anomalyDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA11 |
PTGS1
|
Myotonic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71 |
GSK3B
|
Parasitic infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D0Y-1G2Z |
ALPL
|
ChemoprotectionDisease Category: NADisease ICD-11 Code: N.A. |
TOP2A
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
PTGS1
|
Autoimmune diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40-4A45 |
RORC
|
Ataxic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A03 |
PTGS1
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
MTOR
|
Spinal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84 |
PTGS1
|
MastocytosisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A21 |
FLT3
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TOP2A
|
Inherited coagulation factor deficiencyDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B14 |
PTGS1
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
TOP2A
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
FLT3
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
XDH
|
MigraineDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80 |
PTGS1
|
SyphilisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A61-1A6Z |
TOP2A
|
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
TOP2A
|
Cerebral ischaemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B1Z |
PTGS1
|
Gonococcal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A70-1A7Z |
TOP2A
|
Synthesis disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52-5C59 |
CES1
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
MTOR
|
Bone/articular cartilage neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7B |
FLT3
|
Joint painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME82 |
PTGS1
|
Bleeding disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA20-GA21 |
F3
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
PTGS1
|
Ureteral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C92 |
AHR
|
Unspecified viral infection of unspecified siteDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D9Z |
FLT3
|
Autonomic nervous system disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D87 |
SNCA
|
Inflammatory spondyloarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA92 |
PTGS1
|
Genetic prion diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E02 |
ALPL
|
Fragile X chromosomeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD55 |
GSK3B
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
TYR
|
Acquired hypermelanosisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED60 |
TYR
|
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
FLT3
|
VasculitisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44 |
PTGS1
|
Human immunodeficiency virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C60-1C62 |
FLT3
|
Nutritional deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B50-5B71 |
PTGS1
|
Coronavirus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D92 |
CSNK2A1
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
CYP2D6
|
Anogenital wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A95 |
TOP2A
|
Reactive arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA11 |
PTGS1
|
Common wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E80 |
TOP2A
|
Colon cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
ALPL
|
Inborn purine/pyrimidine/nucleotide metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C55 |
XDH
|
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
FLT3
|
HydrocephalusDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D64 |
MTOR
|
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34 |
PTGS1
|
Mineral deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B5K |
XDH
|
Peroxisomal diseaseDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C57 |
CES1
|
Transplanted organ/tissueDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QB63 |
FLT3
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
TOP2A
|
Urinary system diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC2Z |
PTGS1
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
MTOR
|
EncephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E47 |
XDH
|
Pregnancy/childbirth/puerperium maternal infectionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB63 |
NCT01635426
|
Astrocytoma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH96C7 |
NCT02372409
|
Other chest painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD30.1 |
NCT03820466
|
AngiosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B56 |
NCT04859465
|
Extranodal NK/T-cell lymphoma, nasal typeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.6 |
NCT00725231
|
Carcinosarcoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH2W45 |
NCT00815945
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
NCT00479128
|
Mixed tumour, malignant, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0V86 |
NCT01969578
|
Schizophrenia or other primary psychotic disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A2Z |
NCT02047539
|
Malignant neoplasms of other or unspecified parts of mouthDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B66 |
NCT05456022
|
BlindnessDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9D90.6 |
NCT00000151
|
Single episode depressive disorder, severe, without psychotic symptomsDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70.3 |
NCT03152409
|
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
NCT02116530
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
NCT03152409
|
OligoastrocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH6F49 |
NCT02372409
|
Optic nerve disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C40 |
NCT02372409
|
Columnar metaplastic epithelium of the oesophagus, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA23.Z |
NCT02521285
|
Cutaneous T-cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1951 |
NCT02192021
|
HypercholesterolaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.0 |
NCT01362218
|
Malignant lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5FJ5 |
NCT00126243
|
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
NCT01328236
|
Late effects of cerebral ischemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B25.0 |
NCT00235248
|
Gastrointestinal bleeding, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME24.9Z |
NCT00557921
|
Acute non-ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.1 |
NCT03541109
|
LeukoplakiaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01.00 |
NCT01238185
|
Injury of lung, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NB32.3Z |
NCT01659307
|
HypertriglyceridaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.1 |
NCT01486433
|
Malignant neoplasm metastasis in bone or bone marrowDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E03 |
NCT03678883
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT00178464
|
FatigueDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG22 |
NCT03051646
|
Low back painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.2 |
NCT01028079
|
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT03170115
|
Intrauterine growth restriction, unspecifiedDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA20.1Z |
NCT04557475
|
Malignant neoplasms of prostate, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.Z |
NCT02420652
|
Malignant neoplasm of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.0 |
NCT01272557
|
Cerebrovascular diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B22-8B2Z |
NCT00000479
|
NasopharyngitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA00 |
NCT01453400
|
Acute leukaemias of ambiguous lineageDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A61 |
NCT02419755
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT00486512
|
Diseases of the circulatory system, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BE2Z |
NCT00775762
|
Duodenal ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA63 |
NCT01646814
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT01496521
|
Disseminated intravascular coagulationDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B20 |
NCT04363840
|
Malignant mixed epithelial mesenchymal tumour of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D.0 |
NCT02822157
|
Schizoaffective disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A21 |
NCT01320982
|
LiposarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B59 |
NCT05218499
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
NCT02984384
|
ThrombophiliaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B61 |
NCT01046942
|
OsteonecrosisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB81 |
NCT03405974
|
GanglioneuroblastomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH77W7 |
NCT03786783
|
Primary sclerosing cholangitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96.2 |
NCT03216876
|
AdenomyosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA11 |
NCT04535804
|
Alcoholic liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94 |
NCT05428072
|
Viral pneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.1 |
NCT04368377
|
Burkitt-like lymphoma with 11q aberrationDisease Category: X.Extension CodesDisease ICD-11 Code: XH8NN2 |
NCT02228772
|
Other specified amyloidosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5D00.Y |
NCT00030381
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT04284397
|
Mature B-cell neoplasms, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A8Z |
NCT02911142
|
Chronic myeloid leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4XG8 |
NCT04160546
|
Respiratory failureDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB41 |
NCT04368377
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
NCT00000151
|
Vitamin D deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B57 |
NCT04363840
|
Adenoid cystic carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4302 |
NCT00581360
|
Thymic carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH6AK2 |
NCT01100944
|
Adult T-cell leukaemia/lymphoma (HTLV-1 positive)Disease Category: X.Extension CodesDisease ICD-11 Code: XH6TE2 |
NCT00145002
|
Lymphoplasmacytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85.4 |
NCT00801281
|
Ductal carcinoma in situ of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65.2 |
NCT00461344
|
Choroid plexus tumoursDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.22 |
NCT01014767
|
ThymomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
NCT01100944
|
Hypertrophic cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.1 |
NCT02674958
|
ulcer diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA61-DA63.Y |
NCT00688428
|
Transitional cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8EH1 |
NCT02412670
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NCT00587496
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT00801281
|
Postherpetic polyneuropathyDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E91.5 |
NCT00566904
|
Oligodendroglioma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH7W59 |
NCT02372409
|
Chronic rheumatic heart diseases, not elsewhere classifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC20 |
NCT02832531
|
Retinal vascular occlusionDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B74 |
NCT00732927
|
Transient ischaemic attackDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10 |
NCT00235248
|
Maternal care for fetal growth restrictionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA86.4 |
NCT01616615
|
CholangiocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7M15 |
NCT02994251
|
Malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
NCT03678883
|
Metastatic lung neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D70 |
NCT03678883
|
Castlemans diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B2Y |
NCT02228512
|
Fracture of unspecified body regionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56.2 |
NCT03765619
|
Blood-forming organ diseaseDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3C0Z |
NCT04363840
|
Pilocytic astrocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH12D2 |
NCT02372409
|
Carcinoma of male breastDisease Category: X.Extension CodesDisease ICD-11 Code: XH5KW8 |
NCT00470301
|
Chronic myelogenous leukaemia, BCR-ABL1-positiveDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20.0 |
NCT01424982
|
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
NCT01784159
|
Diseases of the blood or blood-forming organs, unspecifiedDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3C0Z |
NCT04243434
|
Hereditary breast and ovarian cancer syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C65 |
NCT02978495
|
Idiopathic pulmonary fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03.4 |
MMP12
|
KeratoconusDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A78.50 |
CA4
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NOX4
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
MMP12
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
CYP1B1
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
FLT3
|
Ebola virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D60.01 |
HSD17B2
|
❱❱❱ Network Visualization of Plant-Targeted Human Disease Associations
Plant-Targeted Human Disease Network
>> Targets derived from weak experimental activities
